CN115974717A - Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation method and application thereof - Google Patents
Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation method and application thereof Download PDFInfo
- Publication number
- CN115974717A CN115974717A CN202211560250.1A CN202211560250A CN115974717A CN 115974717 A CN115974717 A CN 115974717A CN 202211560250 A CN202211560250 A CN 202211560250A CN 115974717 A CN115974717 A CN 115974717A
- Authority
- CN
- China
- Prior art keywords
- preparation
- compound
- reaction
- ether
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 bisamide compound Chemical class 0.000 title claims abstract description 108
- 238000002360 preparation method Methods 0.000 title claims abstract description 66
- 150000001875 compounds Chemical class 0.000 title claims abstract description 57
- FKTXDTWDCPTPHK-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical group FC(F)(F)[C](F)C(F)(F)F FKTXDTWDCPTPHK-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000008569 process Effects 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 72
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 71
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 51
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 47
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 46
- 239000013078 crystal Substances 0.000 claims description 46
- 239000002904 solvent Substances 0.000 claims description 38
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 36
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 32
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 29
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims description 28
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 24
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 23
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- 238000007126 N-alkylation reaction Methods 0.000 claims description 20
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 20
- 238000007112 amidation reaction Methods 0.000 claims description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 18
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 16
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 14
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 claims description 14
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 13
- 238000005893 bromination reaction Methods 0.000 claims description 13
- 229910052731 fluorine Inorganic materials 0.000 claims description 13
- 239000011737 fluorine Substances 0.000 claims description 13
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 12
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 12
- 239000003513 alkali Substances 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 12
- YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 claims description 11
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 11
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 11
- 239000008096 xylene Substances 0.000 claims description 11
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 10
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000007810 chemical reaction solvent Substances 0.000 claims description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 10
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 9
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 9
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 claims description 8
- 125000006227 2-n-butoxyethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 8
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 8
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 claims description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 7
- 239000012312 sodium hydride Substances 0.000 claims description 7
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 6
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 claims description 6
- MMYKTRPLXXWLBC-UHFFFAOYSA-N 1-bromo-2-ethoxyethane Chemical compound CCOCCBr MMYKTRPLXXWLBC-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- BQYZDMNAARQHKR-UHFFFAOYSA-N 1-(2-bromoethoxy)propane Chemical compound CCCOCCBr BQYZDMNAARQHKR-UHFFFAOYSA-N 0.000 claims description 5
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 claims description 5
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 claims description 5
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- WOLUYEFMPZAHNN-UHFFFAOYSA-N 1-(2-bromoethoxy)butane Chemical compound CCCCOCCBr WOLUYEFMPZAHNN-UHFFFAOYSA-N 0.000 claims description 4
- JOZWPJGRGUOZGY-UHFFFAOYSA-N 1-bromo-3-ethoxypropane Chemical compound CCOCCCBr JOZWPJGRGUOZGY-UHFFFAOYSA-N 0.000 claims description 4
- CEVMYGZHEJSOHZ-UHFFFAOYSA-N 1-bromo-3-methoxypropane Chemical compound COCCCBr CEVMYGZHEJSOHZ-UHFFFAOYSA-N 0.000 claims description 4
- KYKUZTBLYLKPIT-UHFFFAOYSA-N 2-(2-bromoethoxy)propane Chemical compound CC(C)OCCBr KYKUZTBLYLKPIT-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000007809 chemical reaction catalyst Substances 0.000 claims description 3
- 125000005997 bromomethyl group Chemical group 0.000 claims description 2
- CSAJUFLXZFOWKO-UHFFFAOYSA-N 3-methyl-4h-imidazol-5-one Chemical compound CN1CC(=O)N=C1 CSAJUFLXZFOWKO-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 87
- 230000000749 insecticidal effect Effects 0.000 abstract description 6
- 238000009776 industrial production Methods 0.000 abstract description 4
- 239000012467 final product Substances 0.000 abstract description 3
- FTQWRYSLUYAIRQ-UHFFFAOYSA-N n-[(octadecanoylamino)methyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCNC(=O)CCCCCCCCCCCCCCCCC FTQWRYSLUYAIRQ-UHFFFAOYSA-N 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 description 67
- 230000015572 biosynthetic process Effects 0.000 description 59
- 239000002994 raw material Substances 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 239000011734 sodium Substances 0.000 description 32
- 239000003054 catalyst Substances 0.000 description 28
- 238000004128 high performance liquid chromatography Methods 0.000 description 28
- 239000007787 solid Substances 0.000 description 27
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 26
- 239000000843 powder Substances 0.000 description 23
- 239000000463 material Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 239000000543 intermediate Substances 0.000 description 19
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 18
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 238000010992 reflux Methods 0.000 description 16
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 16
- 238000004949 mass spectrometry Methods 0.000 description 15
- 235000011121 sodium hydroxide Nutrition 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 239000011521 glass Substances 0.000 description 13
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 13
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- 230000035484 reaction time Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241000500437 Plutella xylostella Species 0.000 description 11
- 150000001408 amides Chemical class 0.000 description 11
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 229940095102 methyl benzoate Drugs 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- WLGUSLGYTNJJFV-UHFFFAOYSA-N 2-fluoro-3-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1F WLGUSLGYTNJJFV-UHFFFAOYSA-N 0.000 description 8
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 235000017550 sodium carbonate Nutrition 0.000 description 8
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000005711 Benzoic acid Substances 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 235000010233 benzoic acid Nutrition 0.000 description 6
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical class ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- WZCZMWMNVHEBCK-UHFFFAOYSA-N 3-amino-2-fluorobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1F WZCZMWMNVHEBCK-UHFFFAOYSA-N 0.000 description 5
- 241000256251 Spodoptera frugiperda Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- UOYDNSRSUSNCKS-UHFFFAOYSA-N methyl 3-amino-2-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(N)=C1F UOYDNSRSUSNCKS-UHFFFAOYSA-N 0.000 description 5
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 235000011118 potassium hydroxide Nutrition 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 4
- CZKLEJHVLCMVQR-UHFFFAOYSA-N 4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1 CZKLEJHVLCMVQR-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- 238000002050 diffraction method Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000004210 ether based solvent Substances 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 229940102396 methyl bromide Drugs 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- OGMQJQFBXQXEMF-UHFFFAOYSA-N 3-[benzoyl(methyl)amino]-2-fluorobenzoic acid Chemical compound C=1C=CC(C(O)=O)=C(F)C=1N(C)C(=O)C1=CC=CC=C1 OGMQJQFBXQXEMF-UHFFFAOYSA-N 0.000 description 3
- AGTAFYOPVYMEHL-UHFFFAOYSA-N 3-benzamido-2-fluorobenzoic acid Chemical compound C(C1=CC=CC=C1)(=O)NC=1C(=C(C(=O)O)C=CC=1)F AGTAFYOPVYMEHL-UHFFFAOYSA-N 0.000 description 3
- BBYDXOIZLAWGSL-UHFFFAOYSA-N 4-fluorobenzoic acid Chemical compound OC(=O)C1=CC=C(F)C=C1 BBYDXOIZLAWGSL-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 230000009435 amidation Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 2
- YJUUZFWMKJBVFJ-UHFFFAOYSA-N 1,3-dimethylimidazolidin-4-one Chemical compound CN1CN(C)C(=O)C1 YJUUZFWMKJBVFJ-UHFFFAOYSA-N 0.000 description 2
- BVNGWSVCJVPICT-UHFFFAOYSA-N 3-[benzoyl(ethyl)amino]-2-fluorobenzoic acid Chemical compound C=1C=CC(C(O)=O)=C(F)C=1N(CC)C(=O)C1=CC=CC=C1 BVNGWSVCJVPICT-UHFFFAOYSA-N 0.000 description 2
- XANNCKCAPUQNSR-UHFFFAOYSA-N 3-[cyclopropylmethyl-(4-fluorobenzoyl)amino]-2-fluorobenzoic acid Chemical group C1(CC1)CN(C(C1=CC=C(C=C1)F)=O)C=1C(=C(C(=O)O)C=CC=1)F XANNCKCAPUQNSR-UHFFFAOYSA-N 0.000 description 2
- JNVWIZVZNZAVRK-UHFFFAOYSA-N 4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(C(F)(F)F)C(F)(F)F)C=C1C(F)(F)F JNVWIZVZNZAVRK-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 239000005886 Chlorantraniliprole Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 241000220259 Raphanus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 2
- QSLZKWPYTWEWHC-UHFFFAOYSA-N broflanilide Chemical compound C=1C=CC(C(=O)NC=2C(=CC(=CC=2Br)C(F)(C(F)(F)F)C(F)(F)F)C(F)(F)F)=C(F)C=1N(C)C(=O)C1=CC=CC=C1 QSLZKWPYTWEWHC-UHFFFAOYSA-N 0.000 description 2
- 150000003842 bromide salts Chemical class 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MFXTZNGCDRNCKK-UHFFFAOYSA-N ethyl 2-fluoro-3-nitrobenzoate Chemical compound CCOC(=O)C1=CC=CC([N+]([O-])=O)=C1F MFXTZNGCDRNCKK-UHFFFAOYSA-N 0.000 description 2
- VYXXXMWMWZGHDK-UHFFFAOYSA-N ethyl 3-amino-2-fluorobenzoate Chemical compound CCOC(=O)C1=CC=CC(N)=C1F VYXXXMWMWZGHDK-UHFFFAOYSA-N 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- VEKYKLDXYNUERO-UHFFFAOYSA-N methyl 2-fluoro-3-nitrobenzoate Chemical compound COC(=O)C1=CC=CC([N+]([O-])=O)=C1F VEKYKLDXYNUERO-UHFFFAOYSA-N 0.000 description 2
- 238000013386 optimize process Methods 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- BBZVTTKMXRPMHZ-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoro-2-iodopropane Chemical compound FC(F)(F)C(F)(I)C(F)(F)F BBZVTTKMXRPMHZ-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- VBLXCTYLWZJBKA-UHFFFAOYSA-N 2-(trifluoromethyl)aniline Chemical compound NC1=CC=CC=C1C(F)(F)F VBLXCTYLWZJBKA-UHFFFAOYSA-N 0.000 description 1
- SULCAUVYSILBCB-UHFFFAOYSA-N 2-bromo-1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)(Br)C(F)(F)F SULCAUVYSILBCB-UHFFFAOYSA-N 0.000 description 1
- FTZQXOJYPFINKJ-UHFFFAOYSA-N 2-fluoroaniline Chemical compound NC1=CC=CC=C1F FTZQXOJYPFINKJ-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- ADCUEPOHPCPMCE-UHFFFAOYSA-N 4-cyanobenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C=C1 ADCUEPOHPCPMCE-UHFFFAOYSA-N 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- LYIAUOYTTMJKPH-UHFFFAOYSA-N CC(O)(C)C.CC(C)(C)[O-].[Na+] Chemical compound CC(O)(C)C.CC(C)(C)[O-].[Na+] LYIAUOYTTMJKPH-UHFFFAOYSA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940064734 aminobenzoate Drugs 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- KFVDQAUKLNZXPD-UHFFFAOYSA-N methyl 3-benzamido-2-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(NC(=O)C=2C=CC=CC=2)=C1F KFVDQAUKLNZXPD-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- BCPKQFZUOLYXAF-UHFFFAOYSA-N sodium;propan-2-ol;propan-2-olate Chemical compound [Na+].CC(C)O.CC(C)[O-] BCPKQFZUOLYXAF-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本发明请求两项本国优先权,分别为优先权日为2021年12月22日、优先权号为CN2021115835066、名称为“一种含七氟异丙基的双酰胺类化合物及其制备方法和应用”的发明专利申请和优先权日为2022年10月24日、优先权号为CNThe present invention requests two domestic priority rights, namely, the priority date is December 22, 2021, the priority number is CN2021115835066, and the name is "a bisamide compound containing heptafluoroisopropyl group and its preparation method and application." "'s invention patent application and priority date is October 24, 2022, and the priority number is CN
2022113037189、名称为“一种含七氟异丙基的双酰胺类化合物及其中间体化合物,其制备方法与用途”的发明专利申请。2022113037189, an invention patent application titled "a bisamide compound containing heptafluoroisopropyl group and its intermediate compound, its preparation method and application".
【技术领域】【Technical field】
本发明属于杀虫剂领域,涉及一种含七氟异丙基的双酰胺类化合物及其中间体化合物,还涉及它们的制备方法,还涉及含七氟异丙基的双酰胺类化合物结晶体的x-射线粉末衍射特性,及它们的用途。The invention belongs to the field of insecticides, and relates to a heptafluoroisopropyl-containing bisamide compound and an intermediate compound thereof, a preparation method thereof, and a preparation of a heptafluoroisopropyl-containing bisamide compound crystal X-ray powder diffraction properties, and their uses.
【技术背景】【technical background】
由于杀虫剂的大量频繁的使用,目前在全球大部分地区造成了严重的抗性问题,必须增加剂量才能起到原有的效果,有些病害已无药可治,对农业生产、环境、生态势必造成一定的问题。需要推出活性更好、用量更低、环境更友好的新型杀虫剂。国内外科研机构及企业不断加大对农药创制的投入,出现了多个活性高、用量低、环境友好的新型杀虫剂。Due to the large and frequent use of pesticides, serious resistance problems have been caused in most parts of the world at present, and the original effect must be achieved by increasing the dose. It is bound to cause certain problems. It is necessary to introduce new insecticides with better activity, lower consumption and more environmental friendliness. Domestic and foreign scientific research institutions and enterprises have continuously increased their investment in the development of pesticides, and many new pesticides with high activity, low dosage and environmental friendliness have emerged.
日本三井化学公司与巴斯夫公司共同合作开发的间二酰胺类杀虫剂Broflanilide(结构式:01),现已经商业化,中文名称:溴虫氟苯双酰胺,主要用于果蔬、豆类、棉花、玉米、谷物、花卉及非作物用途,防治鳞翅目、鞘翅目、白蚁、蚁类、蜚蠊、蝇类等害虫,具有非常好的效果,详见中国专利CN102119173B,酰胺衍生物、含有该酰胺衍生物的有害生物防除剂及其使用方法。但国内多家企业及研究机构在此基础上进行了结构优化及改进,发现了一系列活性更高、用量更低、环境更友好的新型杀虫剂。中国专利CN 109497062B一种间二酰胺类化合物及其制备方法和应用,代表性结构,环丙氟虫胺(结构式:02);我们发现一种含七氟异丙基的双酰胺类化合物,结构通式(Ⅱ)具有较高的杀虫活性,代表性结构(结构式:03);使得在农业及园艺等作物生产中,提供了更多的用药选择与用药方案。Broflanilide (structural formula: 01), an intermediate diamide insecticide jointly developed by Mitsui Chemicals Corporation of Japan and BASF, has been commercialized now. For corn, grain, flowers and non-crop purposes, it can prevent and control pests such as Lepidoptera, Coleoptera, termites, ants, cockroaches, flies, etc., and has very good effects. For details, see Chinese patent CN102119173B, amide derivatives, containing the amide Derivative pest control agents and methods of use thereof. However, many domestic enterprises and research institutions have optimized and improved the structure on this basis, and have discovered a series of new insecticides with higher activity, lower dosage, and more environmental friendliness. Chinese patent CN 109497062B is a kind of intermediate diamide compound and its preparation method and application, representative structure, ciprofluramid (structural formula: 02); we found a bisamide compound containing heptafluoroisopropyl, the structure The general formula (II) has high insecticidal activity, and the representative structure (structural formula: 03) provides more medication options and medication schemes in the production of crops such as agriculture and horticulture.
其中,R1取代基独立地选自H、氟、三氟甲基、氰基或硝基;Wherein, the substituents of R are independently selected from H, fluorine, trifluoromethyl, cyano or nitro;
R2取代基独立地选自2-甲氧基乙基、2-乙氧基乙基、3-甲氧基丙基、3-乙氧基丙基、2-正丙氧基乙基、2-异丙氧基乙基、2-正丁氧基乙基、环丙基甲基、甲基或乙基。R The substituents are independently selected from 2- methoxyethyl, 2-ethoxyethyl, 3-methoxypropyl, 3-ethoxypropyl, 2-n-propoxyethyl, 2 - isopropoxyethyl, 2-n-butoxyethyl, cyclopropylmethyl, methyl or ethyl.
但相关化合物制备工艺存在路线复杂、化学反应条件苛刻、选择性差、环境不友好、总收率偏低、提纯困难或工艺成本过高等缺点,不利于工业化生产与规模化应用。详细可参阅相关文献或专利,如:柳爱平,等。溴虫氟苯双酰胺(Broflanilide)的合成与生物活性,精细化工中间体期刊,2020年12月,第50卷第6期16-20页。However, the preparation process of related compounds has disadvantages such as complex routes, harsh chemical reaction conditions, poor selectivity, unfriendly environment, low total yield, difficult purification or high process cost, which is not conducive to industrial production and large-scale application. For details, please refer to related documents or patents, such as: Liu Aiping, etc. Synthesis and biological activity of broflanilide, Journal of Fine Chemical Intermediates, December 2020,
【发明内容】【Content of invention】
针对现有技术的不足,本发明目的在于通过制备工艺流程的优化设计,反应条件的优化改进,提供一种制备工艺流程操作简单、化学反应条件温和、环境友好、总收率高、最终产品含量高、成本低、易于产业化生产的含七氟异丙基的双酰胺类化合物及其制备方法,还涉及用于制备所述含七氟异丙基的双酰胺类化合物的中间体化合物及其制备方法。Aiming at the deficiencies of the prior art, the object of the present invention is to provide a preparation process with simple operation, mild chemical reaction conditions, environment-friendly, high total yield, and low final product content by optimizing the design of the preparation process and optimizing the reaction conditions. A heptafluoroisopropyl-containing bisamide compound that is high in cost, low in cost, and easy for industrial production and a preparation method thereof, and also relates to an intermediate compound and its preparation method for the preparation of the heptafluoroisopropyl-containing bisamide compound Preparation.
为达此目的,本发明提供一种用于制备含七氟异丙基的双酰胺类化合物的中间体化合物的制备方法,所述中间体如下通式(Ⅰ)所示,To achieve this purpose, the present invention provides a method for preparing an intermediate compound for the preparation of bisamide compounds containing heptafluoroisopropyl, the intermediate being shown in the following general formula (I):
其中,R1取代基独立地选自H、氟、三氟甲基、氰基或硝基;Wherein, the substituents of R are independently selected from H, fluorine, trifluoromethyl, cyano or nitro;
R2取代基独立地选自2-甲氧基乙基、2-乙氧基乙基、3-甲氧基丙基、3-乙氧基丙基、2-正丙氧基乙基、2-异丙氧基乙基、2-正丁氧基乙基、环丙基甲基、甲基或乙基。R The substituents are independently selected from 2- methoxyethyl, 2-ethoxyethyl, 3-methoxypropyl, 3-ethoxypropyl, 2-n-propoxyethyl, 2 - isopropoxyethyl, 2-n-butoxyethyl, cyclopropylmethyl, methyl or ethyl.
其特征在于所述的通式(Ⅰ)所示结构的中间体化合物制备方法的工艺流程如式(1)或式(2):It is characterized in that the process flow of the preparation method of the intermediate compound with the structure shown in the general formula (I) is as formula (1) or formula (2):
其中,R3为C1-C5的烷基;Wherein, R 3 is an alkyl group of C1-C5;
式(1)或式(2)中所述N-烷基化反应溶剂选自:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、N-甲基吡咯烷酮、1,3-二甲基-2-咪唑啉酮、二甲基亚砜、乙腈、四氢呋喃、二氯乙烷、环己烷、甲基环己烷、甲苯、乙苯、二甲苯中的一种或多种混合物;The N-alkylation reaction solvent described in formula (1) or formula (2) is selected from: N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylformamide Amide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolinone, dimethylsulfoxide, acetonitrile, tetrahydrofuran, dichloroethane, cyclohexane, methylcyclohexane, toluene, ethyl One or more mixtures of benzene and xylene;
式(1)或式(2)中所述N-烷基化反应碱选自:碳酸钾、碳酸钠、氢化钠;The N-alkylation reaction alkali described in formula (1) or formula (2) is selected from: potassium carbonate, sodium carbonate, sodium hydride;
式(1)或式(2)中所述N-烷基化反应溴代烷选自:2-甲氧基溴乙烷、2-乙氧基溴乙烷、3-甲氧基溴丙烷、3-乙氧基溴丙烷、2-正丙氧基溴乙烷、2-异丙氧基溴乙烷、2-正丁氧基溴乙烷、溴甲基环丙烷、溴甲烷或溴乙烷;The N-alkylation bromoalkane described in formula (1) or formula (2) is selected from: 2-methoxy bromoethane, 2-ethoxy bromoethane, 3-methoxy bromopropane, 3-Ethoxybromopropane, 2-n-propoxybromoethane, 2-isopropoxybromoethane, 2-n-butoxybromoethane, bromomethylcyclopropane, bromomethyl or bromoethane;
式(1)或式(2)中所述N-烷基化反应催化剂选自:十六烷基三甲基氯化铵、苄基三乙基氯化铵、聚乙二醇400-800、四丁基氯化铵、四丁基溴化铵、四丁基硫酸氢铵、15-冠-5-醚、18-冠-6-醚或4-二甲氨基吡啶(DMAP)中的一种或多种混合物;The N-alkylation reaction catalyst described in formula (1) or formula (2) is selected from: hexadecyltrimethylammonium chloride, benzyltriethylammonium chloride, polyethylene glycol 400-800, One of tetrabutylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium bisulfate, 15-crown-5-ether, 18-crown-6-ether or 4-dimethylaminopyridine (DMAP) or multiple mixtures;
式(2)中所述酰胺化反应溶剂选自:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、N-甲基吡咯烷酮、1,3-二甲基-2-咪唑啉酮、二甲基亚砜、乙腈、四氢呋喃、乙酸乙酯、二氯甲烷、二氯乙烷、环己烷、甲基环己烷、甲苯、乙苯、二甲苯中的一种或多种混合物。The amidation reaction solvent described in formula (2) is selected from: N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylformamide, N-methylpyrrolidone, 1,3-Dimethyl-2-imidazolinone, dimethyl sulfoxide, acetonitrile, tetrahydrofuran, ethyl acetate, dichloromethane, dichloroethane, cyclohexane, methylcyclohexane, toluene, ethyl One or more mixtures of benzene and xylene.
对于上述中间体化合物的制备方法,为达此目的,本发明采用以下技术方案。For the preparation method of above-mentioned intermediate compound, in order to achieve this purpose, the present invention adopts following technical scheme.
首先,使用2-氟-3-硝基苯甲酸原料和相应的醇类,在催化剂存在下进行酯化反应,得到相应的2-氟-3-硝基苯甲酸酯,反应式如下:First, use 2-fluoro-3-nitrobenzoic acid raw material and corresponding alcohols, carry out esterification reaction in the presence of catalyst, obtain corresponding 2-fluoro-3-nitrobenzoic acid ester, reaction formula is as follows:
其中,R3为C1-C5的烷基,优选为甲基、乙基、正丙基、异丙基、正丁基、异丁基,特别优选为甲基或乙基,由相对应的醇类通过酯化反应而制备。Wherein, R 3 is C1-C5 alkyl, preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, particularly preferably methyl or ethyl, from the corresponding alcohol Classes are prepared by esterification.
酯化反应催化剂为浓硫酸、对甲苯磺酸、甲基磺酸、三氟甲基磺酸。优选为浓硫酸,优选质量浓度为80-100%,用量为2-氟-3-硝基苯甲酸原料重量的0.5%-20%,优选为1-5%。醇类,一般选用C1-C5的醇,优选为甲醇、乙醇、正丙醇、异丙醇、正丁醇、异丁醇,特别优选为甲醇或乙醇;用量为2-氟-3-硝基苯甲酸原料重量的2-10倍,优选为3-5倍;反应温度,一般为50-200℃,优选为相应醇的沸点回流反应温度;反应时间,一般为5-48小时,优选反应时间5-24小时。The esterification catalyst is concentrated sulfuric acid, p-toluenesulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid. It is preferably concentrated sulfuric acid, preferably with a mass concentration of 80-100%, and the dosage is 0.5%-20%, preferably 1-5%, of the weight of the 2-fluoro-3-nitrobenzoic acid raw material. Alcohols, generally choose C1-C5 alcohols, preferably methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, especially methanol or ethanol; the dosage is 2-fluoro-3-nitro 2-10 times of benzoic acid raw material weight, preferably 3-5 times; reaction temperature, generally 50-200 ℃, preferably the boiling point reflux reaction temperature of corresponding alcohol; reaction time, generally 5-48 hours, preferably reaction time 5-24 hours.
其中,2-氟-3-硝基苯甲酸是医药、农药重要中间体,有多种合成路线实现,一般可通过市场采购或合成获得,含量一般为工业级95%以上。本发明如果没有特别说明,一般是指通过市场采购获得,本领域技术人员也可通过下列经典合成反应路线实现:Among them, 2-fluoro-3-nitrobenzoic acid is an important intermediate of medicine and pesticide, which can be realized through various synthetic routes. It can generally be obtained through market purchase or synthesis, and its content is generally more than 95% of industrial grade. If the present invention has no special instructions, it generally refers to obtaining it through market purchase, and those skilled in the art can also realize it through the following classic synthesis reaction route:
然后,将所得到的2-氟-3-硝基苯甲酸酯,在溶剂中、在钯炭或雷尼镍催化剂存在下,进行加氢还原反应,将硝基还原为相应的氨基,得到相应的2-氟-3-氨基苯甲酸酯。反应式如下:Then, the obtained 2-fluoro-3-nitrobenzoate is subjected to a hydrogenation reduction reaction in a solvent in the presence of palladium carbon or Raney nickel catalyst, and the nitro group is reduced to the corresponding amino group to obtain The corresponding 2-fluoro-3-aminobenzoate. The reaction formula is as follows:
其中,反应溶剂一般采用,醇类,如:甲醇、乙醇、正丙醇、异丙醇、叔丁醇;醚类,如:四氢呋喃、甲基叔丁基醚、异丙醚、1,4-二氧六环,乙二醇单甲醚、乙二醇单乙醚、乙二醇二甲醚、乙二醇二乙醚等,优选使用醇类,如:甲醇、乙醇、异丙醇、叔丁醇。溶剂使用量为2-氟-3-硝基苯甲酸酯重量的2-20倍,优选使用2-10倍。催化剂一般采用质量浓度Among them, the reaction solvent is generally used, alcohols, such as: methanol, ethanol, n-propanol, isopropanol, tert-butanol; ethers, such as: tetrahydrofuran, methyl tert-butyl ether, isopropyl ether, 1,4- Dioxane, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, etc., preferably alcohols, such as methanol, ethanol, isopropanol, tert-butanol . The amount of solvent used is 2-20 times, preferably 2-10 times, the weight of 2-fluoro-3-nitrobenzoate. Catalysts generally use a mass concentration of
1-5%的钯炭或雷尼镍,优选使用5%的钯炭催化剂,催化剂折干基使用量为2-氟-3-硝基苯甲酸酯重量的0.1%-10%,优选使用1%-5%,从经济考虑,可循环套用5-10次。氢气为工业级99%以上,反应压力为0-2Mpa,优选压力0-0.5Mpa,特优选接近常压反应。1-5% palladium-carbon or Raney nickel, preferably 5% palladium-carbon catalyst, the amount of catalyst used on a dry basis is 0.1%-10% of the weight of 2-fluoro-3-nitrobenzoate, preferably 1%-5%, from economic considerations, can be recycled 5-10 times. The hydrogen is more than 99% of industrial grade, and the reaction pressure is 0-2Mpa, preferably 0-0.5Mpa, especially preferably near normal pressure.
反应温度为0-100℃,优选反应温度为5-50℃。反应时间一般为反应至催化剂不吸氢,一般为2-24小时。The reaction temperature is 0-100°C, preferably 5-50°C. The reaction time is generally until the catalyst does not absorb hydrogen, generally 2-24 hours.
接着,将所得到的2-氟-3-氨基苯甲酸酯(或可以通过市场直接购买获取),在溶剂存在下和系列苯甲酰氯反应得到酰胺中间体。反应式如下:Next, the obtained 2-fluoro-3-aminobenzoic acid ester (or can be purchased directly from the market) is reacted with a series of benzoyl chlorides in the presence of a solvent to obtain an amide intermediate. The reaction formula is as follows:
其中,R1取代基独立地选自H、氟、三氟甲基、氰基或硝基;R3定义同前。Wherein, R substituents are independently selected from H, fluorine, trifluoromethyl, cyano or nitro; R is as defined above.
此处,酰胺化反应所采用的苯甲酰氯系列原料一般由对应苯甲酸系列原料和氯化亚砜在惰性溶剂中通过酰氯化反应后脱溶制备得到,使用量一般为2-氟-3-氨基苯甲酸酯摩尔量的1.0-1.2倍,优选1.0-1.05倍。Here, the benzoyl chloride series raw materials used in the amidation reaction are generally prepared from the corresponding benzoic acid series raw materials and thionyl chloride through acid chloride reaction in an inert solvent, and the amount used is generally 2-fluoro-3- 1.0-1.2 times, preferably 1.0-1.05 times the molar weight of aminobenzoate.
酰胺化反应通常采用的傅酸剂为三乙胺、吡啶、N,N-二异丙基乙胺、N,N-二甲基苯胺、四甲基乙二胺、碳酸氢钠、碳酸钠、碳酸钾、氢氧化钠、氢氧化钾、氢氧化锂、甲醇钠、甲醇钾、叔丁醇钠或叔丁醇钾等,优选采用三乙胺或吡啶,摩尔用量为苯甲酰氯系列原料的0.1-5.0倍,优选的经济用量为0.1-2.0倍;酰胺化反应采用的溶剂为二氯甲烷、氯仿、二氯乙烷、四氢呋喃、二氧六环、二甲基亚砜、乙腈、甲苯、二甲苯、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、N-甲基吡咯烷酮或1,3-二甲基-2-咪唑啉酮等,优选溶剂为二氯乙烷、甲苯、乙腈、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺或1,3-二甲基-2-咪唑啉酮等,用量为苯甲酰氯系列原料重量的1-20倍,优选的经济用量为2-5倍;酰胺化反应温度一般为-5-150℃,优选反应温度0-130℃;反应时间一般为1-5小时,优选1-2小时。Acidic agents commonly used in amidation reactions are triethylamine, pyridine, N,N-diisopropylethylamine, N,N-dimethylaniline, tetramethylethylenediamine, sodium bicarbonate, sodium carbonate, Potassium carbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium methoxide, potassium methoxide, sodium tert-butoxide or potassium tert-butoxide, etc., triethylamine or pyridine is preferably used, and the molar dosage is 0.1% of the benzoyl chloride series raw materials -5.0 times, the preferred economical amount is 0.1-2.0 times; the solvent used in the amidation reaction is dichloromethane, chloroform, dichloroethane, tetrahydrofuran, dioxane, dimethyl sulfoxide, acetonitrile, toluene, di Toluene, N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylformamide, N-methylpyrrolidone or 1,3-dimethyl-2-imidazoline Ketones, etc., the preferred solvent is dichloroethane, toluene, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide or 1,3-dimethyl-2-imidazolidinone, etc., The dosage is 1-20 times the weight of the benzoyl chloride series raw materials, and the preferred economic dosage is 2-5 times; the amidation reaction temperature is generally -5-150°C, and the preferred reaction temperature is 0-130°C; the reaction time is generally 1- 5 hours, preferably 1-2 hours.
所得产物可用于实现本发明的中间体化合物的制备方法,所述方法流程如式(1)The resulting product can be used to realize the preparation method of the intermediate compound of the present invention, and the process flow is as shown in formula (1)
所示:Shown:
其中,R3选自C1-C5的烷基;Wherein, R 3 is selected from the alkyl group of C1-C5;
N-烷基化反应中的溶剂选自:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、N-甲基吡咯烷酮、1,3-二甲基-2-咪唑啉酮、二甲基亚砜、乙腈、四氢呋喃、二氯乙烷、环己烷、甲基环己烷、甲苯、乙苯、二甲苯中的一种或多种混合物;优选溶剂为:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、乙腈、环己烷、甲基环己烷、甲苯中的一种或多种混合物,用量为酰胺或2-氟-3-氨基苯甲酸酯原料重量的2-10倍,优选为2-5倍。The solvent in the N-alkylation reaction is selected from: N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylformamide, N-methylpyrrolidone, 1, One or more of 3-dimethyl-2-imidazolinone, dimethyl sulfoxide, acetonitrile, tetrahydrofuran, dichloroethane, cyclohexane, methylcyclohexane, toluene, ethylbenzene, xylene The preferred solvent is: one or more mixtures of N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, cyclohexane, methylcyclohexane, toluene, dosage It is 2-10 times, preferably 2-5 times, the weight of amide or 2-fluoro-3-aminobenzoate raw material.
N-烷基化反应中的碱选自碳酸钾、碳酸钠、氢氧化钠、氢氧化钾、氢化钠,优选为:碳酸钾、碳酸钠、氢化钠,用量为酰胺或2-氟-3-氨基苯甲酸酯原料摩尔量的1-3倍,优选为1-2倍。The base in the N-alkylation reaction is selected from potassium carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide, sodium hydride, preferably: potassium carbonate, sodium carbonate, sodium hydride, and the amount is amide or 2-fluoro-3- 1-3 times, preferably 1-2 times the molar weight of aminobenzoic acid ester raw material.
N-烷基化反应中的溴代烷选自:2-甲氧基溴乙烷、2-乙氧基溴乙烷、3-甲氧基溴丙烷、3-乙氧基溴丙烷、2-正丙氧基溴乙烷、2-异丙氧基溴乙烷、2-正丁氧基溴乙烷、溴甲基环丙烷、溴甲烷或溴乙烷;通常可以通过市场获取或合成获得,本发明没有特别说明,一般是指通过市场获取。用量为酰胺或2-氟-3-氨基苯甲酸酯原料摩尔量的1-3倍,优选为1-2倍。本发明采用溴代烷,避免使用碘代烷,这是由于碘代烷活性高,但造成工业化成本高,不利于产业化,而溴代烷通常活性较低,选择性差,收率较低,需要在催化剂存在及优化工艺条件下,才能达到较好的效果。Bromoalkane in the N-alkylation reaction is selected from: 2-methoxybromoethane, 2-ethoxybromoethane, 3-methoxybromopropane, 3-ethoxybromopropane, 2- n-propoxybromoethane, 2-isopropoxybromoethane, 2-n-butoxybromoethane, bromomethylcyclopropane, methyl bromide or bromoethane; usually commercially or synthetically available, this Inventions are not specifically stated, and generally refer to acquisition through the market. The dosage is 1-3 times, preferably 1-2 times, the molar weight of the amide or 2-fluoro-3-aminobenzoate raw material. The present invention adopts bromoalkane and avoids the use of iodoalkane, which is due to the high activity of iodoalkane, but causes high industrialization cost and is unfavorable for industrialization, while bromoalkane usually has low activity, poor selectivity, and low yield. Only in the presence of catalysts and optimized process conditions can better results be achieved.
N-烷基化反应中的催化剂选自:十六烷基三甲基氯化铵、苄基三乙基氯化铵、聚乙二醇400-800、四丁基氯化铵、四丁基溴化铵、四丁基硫酸氢铵、15-冠-5-醚、18-冠-6-醚或4-二甲氨基吡啶(DMAP)中的一种或多种混合物。此外,催化剂也可采用碘化物盐,如:碘化钾、碘化钠等,但催化效果不及相转移催化剂或4-二甲氨基吡啶(DMAP),优选使用为四丁基氯化铵、四丁基溴化铵、四丁基硫酸氢铵、18-冠-6-醚或4-二甲氨基吡啶(DMAP),催化剂用量为酰胺或2-氟-3-氨基苯甲酸酯原料重量的1-10%,优选为1-5%,本发明使用催化剂,可降低反应温度,提高反应选择性及产品收率。The catalyst in the N-alkylation reaction is selected from: cetyltrimethylammonium chloride, benzyltriethylammonium chloride, polyethylene glycol 400-800, tetrabutylammonium chloride, tetrabutylammonium One or more mixtures of ammonium bromide, tetrabutylammonium bisulfate, 15-crown-5-ether, 18-crown-6-ether or 4-dimethylaminopyridine (DMAP). In addition, the catalyst can also use iodide salts, such as: potassium iodide, sodium iodide, etc., but the catalytic effect is not as good as phase transfer catalysts or 4-dimethylaminopyridine (DMAP), preferably tetrabutylammonium chloride, tetrabutylammonium chloride, etc. Ammonium bromide, tetrabutylammonium bisulfate, 18-crown-6-ether or 4-dimethylaminopyridine (DMAP), the catalyst dosage is 1- 10%, preferably 1-5%. The catalyst used in the present invention can reduce the reaction temperature and improve the reaction selectivity and product yield.
本发明还提供上述中间体化合物的另一种制备方法,所述方法流程如式(2)所示:The present invention also provides another preparation method of the above-mentioned intermediate compound, the process flow of which is shown in formula (2):
与第一种制备方法类似,R3选自C1-C5的烷基;Similar to the first preparation method, R3 is selected from C1-C5 alkyl groups;
N-烷基化反应中的溶剂选自:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、N-甲基吡咯烷酮、1,3-二甲基-2-咪唑啉酮、二甲基亚砜、乙腈、四氢呋喃、二氯乙烷、环己烷、甲基环己烷、甲苯、乙苯、二甲苯中的一种或多种混合物;优选溶剂为:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、乙腈、环己烷、甲基环己烷、甲苯中的一种或多种混合物,用量为酰胺或2-氟-3-氨基苯甲酸酯原料重量的2-10倍,优选为2-5倍。The solvent in the N-alkylation reaction is selected from: N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylformamide, N-methylpyrrolidone, 1, One or more of 3-dimethyl-2-imidazolinone, dimethyl sulfoxide, acetonitrile, tetrahydrofuran, dichloroethane, cyclohexane, methylcyclohexane, toluene, ethylbenzene, xylene The preferred solvent is: one or more mixtures of N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, cyclohexane, methylcyclohexane, toluene, dosage It is 2-10 times, preferably 2-5 times, the weight of amide or 2-fluoro-3-aminobenzoate raw material.
N-烷基化反应中的碱选自碳酸钾、碳酸钠、氢氧化钠、氢氧化钾、氢化钠,优选为碳酸钾、碳酸钠或氢化钠,用量为酰胺或2-氟-3-氨基苯甲酸酯原料摩尔量的1-3倍,优选为1-2倍。The base in the N-alkylation reaction is selected from potassium carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide, sodium hydride, preferably potassium carbonate, sodium carbonate or sodium hydride in an amount of amide or 2-fluoro-3-amino 1-3 times, preferably 1-2 times of the molar weight of benzoic acid ester raw material.
N-烷基化反应中的溴代烷选自:2-甲氧基溴乙烷、2-乙氧基溴乙烷、3-甲氧基溴丙烷、3-乙氧基溴丙烷、2-正丙氧基溴乙烷、2-异丙氧基溴乙烷、2-正丁氧基溴乙烷、溴甲基环丙烷、溴甲烷或溴乙烷;通常可以通过市场获取或合成获得,本发明没有特别说明,一般是指通过市场获取。用量为酰胺或2-氟-3-氨基苯甲酸酯原料摩尔量的1-3倍,优选为1-2倍。本发明采用溴代烷,避免使用碘代烷,这是由于碘代烷活性高,但造成工业化成本高,不利于产业化,而溴代烷通常活性较低,选择性差,收率较低,需要在催化剂存在及优化工艺条件下,才能达到较好的效果。Bromoalkane in the N-alkylation reaction is selected from: 2-methoxybromoethane, 2-ethoxybromoethane, 3-methoxybromopropane, 3-ethoxybromopropane, 2- n-propoxybromoethane, 2-isopropoxybromoethane, 2-n-butoxybromoethane, bromomethylcyclopropane, methyl bromide or bromoethane; usually commercially or synthetically available, this Inventions are not specifically stated, and generally refer to acquisition through the market. The dosage is 1-3 times, preferably 1-2 times, the molar weight of the amide or 2-fluoro-3-aminobenzoate raw material. The present invention adopts bromoalkane and avoids the use of iodoalkane, which is due to the high activity of iodoalkane, but causes high industrialization cost and is unfavorable for industrialization, while bromoalkane usually has low activity, poor selectivity, and low yield. Only in the presence of catalysts and optimized process conditions can better results be achieved.
N-烷基化反应中的催化剂选自:十六烷基三甲基氯化铵、苄基三乙基氯化铵、聚乙二醇400-800、四丁基氯化铵、四丁基溴化铵、四丁基硫酸氢铵、15-冠-5-醚、18-冠-6-醚或4-二甲氨基吡啶(DMAP)中的一种或多种混合物。此外,催化剂也可采用碘化物盐,如:碘化钾、碘化钠等,但催化效果不及相转移催化剂或4-二甲氨基吡啶(DMAP),优选使用为四丁基氯化铵、四丁基溴化铵、四丁基硫酸氢铵、15-冠-5-醚、18-冠-6-醚或4-二甲氨基吡啶(DMAP),催化剂用量为酰胺或2-氟-3-氨基苯甲酸酯原料重量的1-10%,优选为1-5%,本发明使用催化剂,可降低反应温度,提高反应选择性及产品收率。The catalyst in the N-alkylation reaction is selected from: cetyltrimethylammonium chloride, benzyltriethylammonium chloride, polyethylene glycol 400-800, tetrabutylammonium chloride, tetrabutylammonium One or more mixtures of ammonium bromide, tetrabutylammonium bisulfate, 15-crown-5-ether, 18-crown-6-ether or 4-dimethylaminopyridine (DMAP). In addition, the catalyst can also use iodide salts, such as: potassium iodide, sodium iodide, etc., but the catalytic effect is not as good as phase transfer catalysts or 4-dimethylaminopyridine (DMAP), preferably tetrabutylammonium chloride, tetrabutylammonium chloride, etc. Ammonium bromide, tetrabutylammonium bisulfate, 15-crown-5-ether, 18-crown-6-ether or 4-dimethylaminopyridine (DMAP), catalyst dosage is amide or 2-fluoro-3-aminobenzene 1-10%, preferably 1-5%, of the raw material weight of the formate ester, the catalyst used in the present invention can reduce the reaction temperature, improve the reaction selectivity and product yield.
酰胺化反应溶剂选自:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、N-甲基吡咯烷酮、1,3-二甲基-2-咪唑啉酮、二甲基亚砜、乙腈、四氢呋喃、乙酸乙酯、二氯甲烷、二氯乙烷、环己烷、甲基环己烷、甲苯、乙苯、二甲苯中的一种或多种混合物。优选溶剂为:N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、乙腈、四氢呋喃、乙酸乙酯、二氯甲烷、二氯乙烷、甲苯中的一种或多种混合物。用量为苯甲酸系列酰氯原料重量的2-10倍,优选为2-5倍。The amidation reaction solvent is selected from: N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylformamide, N-methylpyrrolidone, 1,3-dimethyl -One of 2-imidazolinone, dimethyl sulfoxide, acetonitrile, tetrahydrofuran, ethyl acetate, dichloromethane, dichloroethane, cyclohexane, methylcyclohexane, toluene, ethylbenzene, xylene one or more mixtures. The preferred solvent is: one or more mixtures of N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, tetrahydrofuran, ethyl acetate, dichloromethane, dichloroethane, toluene . The dosage is 2-10 times, preferably 2-5 times, the weight of the benzoic acid series acid chloride raw material.
其中,酰胺化反应可采用加入DMAP催化剂,用量为苯甲酸系列酰氯原料重量的1-10%,优选为1-5%,在不加入催化剂时,本发明工艺条件下反应收率及反应时间都可接受,所以本发明不一定必须使用;本发明的中间体化合物的制备方法中,酰胺化反应无需要采用傅酸剂,在本发明工艺条件下,转化收率及反应时间都可以接受。其中,酰胺化反应温度为0-200℃,优选为0-150℃Wherein, amidation reaction can adopt to add DMAP catalyst, and consumption is 1-10% of benzoic acid series acid chloride raw material weight, is preferably 1-5%, when not adding catalyzer, reaction yield and reaction time are both under the process conditions of the present invention. Acceptable, so the present invention does not necessarily have to be used; in the preparation method of the intermediate compound of the present invention, the amidation reaction does not need to use a fuacid agent, and under the process conditions of the present invention, the conversion yield and reaction time are acceptable. Wherein, the amidation reaction temperature is 0-200°C, preferably 0-150°C
前述两种中间体化合物的制备方法中水解反应条件一般为通常条件,一般采用醇类溶剂如甲醇、乙醇、异丙醇等,或醚类溶剂如1,4-二氧六环、甲基叔丁基醚、乙二醇二甲醚、乙二醇二乙醚等,优选甲醇、乙醇,使用量一般为对应酯重量的2-10倍,优选2-5倍;碱一般采用氢氧化钠、氢氧化钾、碳酸钠、碳酸钾,优选氢氧化钠,浓度一般采用质量浓度1-35%,摩尔用量为对应酯的1.1-3.0倍。反应温度,一般为5-50℃,优选温度为20-30℃。反应时间一般为1-5小时,优选为1-2小时。In the preparation method of the aforementioned two intermediate compounds, the hydrolysis reaction conditions are generally the usual conditions, generally using alcohol solvents such as methanol, ethanol, isopropanol, etc., or ether solvents such as 1,4-dioxane, methyl tertiary Butyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, etc., methanol and ethanol are preferred, and the amount used is generally 2-10 times the weight of the corresponding ester, preferably 2-5 times; the alkali generally uses sodium hydroxide, hydrogen Potassium oxide, sodium carbonate, potassium carbonate, preferably sodium hydroxide, the concentration generally adopts a mass concentration of 1-35%, and the molar dosage is 1.1-3.0 times of the corresponding ester. The reaction temperature is generally 5-50°C, preferably 20-30°C. The reaction time is generally 1-5 hours, preferably 1-2 hours.
在上述两种中间体化合物的制备方法中,N-烷基化反应温度为50-200℃,优选温度为50-150℃,当溶剂为与水能产生共沸溶剂时,反应温度优选为共沸温度,并可通过共沸脱出反应产生的水,可缩短反应时间;反应压力一般为常压反应,当溴代烷为溴甲烷或溴乙烷时,由于溴代烷沸点低,避免挥发,优选为密闭反应,压力为0-0.2MPa。而N-烷基化反应时间通常为2-12小时,优选2-8小时。In the preparation method of the above two intermediate compounds, the N-alkylation reaction temperature is 50-200°C, preferably the temperature is 50-150°C, and when the solvent is a solvent capable of producing azeotropy with water, the reaction temperature is preferably Boiling temperature, and the water produced by the reaction can be removed by azeotropy, which can shorten the reaction time; the reaction pressure is generally normal pressure reaction, when bromoalkane is methyl bromide or bromoethane, due to the low boiling point of bromoalkane, avoid volatilization, preferably For closed reaction, the pressure is 0-0.2MPa. The N-alkylation reaction time is usually 2-12 hours, preferably 2-8 hours.
进一步地,本发明还提供一种含七氟异丙基的双酰胺类化合物,所述化合物的结构如通式(II)所示,Further, the present invention also provides a heptafluoroisopropyl-containing bisamide compound, the structure of which is shown in the general formula (II),
其中,R1取代基独立地选自H、氟、三氟甲基、氰基或硝基;Wherein, the substituents of R are independently selected from H, fluorine, trifluoromethyl, cyano or nitro;
R2取代基独立地选自2-甲氧基乙基、2-乙氧基乙基、3-甲氧基丙基、3-乙氧基丙基、2-正丙氧基乙基、2-异丙氧基乙基、2-正丁氧基乙基、环丙基甲基、甲基或乙基。R The substituents are independently selected from 2- methoxyethyl, 2-ethoxyethyl, 3-methoxypropyl, 3-ethoxypropyl, 2-n-propoxyethyl, 2 - isopropoxyethyl, 2-n-butoxyethyl, cyclopropylmethyl, methyl or ethyl.
本发明还提供上述含七氟异丙基的双酰胺类化合物的制备方法,所述方法流程如式(3)所示:The present invention also provides a method for preparing the above-mentioned heptafluoroisopropyl-containing bisamide compounds, the process flow of which is shown in formula (3):
其中,酰氯化反应的通常方法为通式(Ⅰ)原料在惰性溶剂中和氯化亚砜反应,脱溶处理进入下一步反应。酰氯化反应所采用的溶剂为二氯甲烷、氯仿、二氯乙烷、甲苯或二甲苯等,优选溶剂为二氯乙烷或甲苯等;酰氯化反应温度一般为20-150℃,优选反应温度40-100℃;酰氯化反应时间一般为1-5小时,优选2-3小时。Wherein, the general method of acyl chloride reaction is that the raw material of general formula (I) reacts with thionyl chloride in an inert solvent, and the precipitation treatment enters the next step of reaction. The solvent used in the acid chloride reaction is methylene chloride, chloroform, ethylene dichloride, toluene or xylene, etc., the preferred solvent is ethane dichloride or toluene, etc.; the acid chloride reaction temperature is generally 20-150 ° C, the preferred reaction temperature 40-100°C; acid chloride reaction time is generally 1-5 hours, preferably 2-3 hours.
酰胺化反应中的溶剂选自二氯甲烷、二氯乙烷、环己烷、甲基环己烷、甲苯、乙苯、二甲苯、乙酸乙酯、四氢呋喃或乙腈中的一种或多种混合物;优选使用溶剂为二氯乙烷、环己烷、甲基环己烷、甲苯、乙酸乙酯或乙腈,使用量一般为对应通式(Ⅰ)原料重量的2-10倍,优选3-8倍。酰胺化也可以使用催化剂4-二甲氨基吡啶(DMAP),可缩短反应时间,但在本发明优选条件下,酰胺化无需使用催化剂及傅酸剂,反应收率及反应时间都可接受,所以本发明不一定必须使用。酰胺化反应另一原料4-七氟异丙基-2-三氟甲基苯胺可以通过合成或市场购买获取,合成方法是由邻三氟甲基苯胺原料和2-溴七氟丙烷或2-碘七氟丙烷在保险粉存在下,烷基化反应制备而得,合成详见中国发明专利CN 102119173B公开的内容。原料4-七氟异丙基-2-三氟甲基苯胺的使用量为通式(Ⅰ)原料摩尔量的1.0-1.3倍,优选使用量为1.0-1.05倍。溴化反应使用液溴为溴化剂,价格便宜,原料易得,副产物溴化盐易于回收利用,相比N-溴代琥珀酰亚胺溴化剂成本低,又利于环保,使用量为通式(Ⅰ)原料摩尔量的1-2倍,优选使用量为1-1.5倍,优选使用方式为滴入反应,也可采用紫外光照条件下滴入反应,优选不需要光照,就能进行反应。The solvent in the amidation reaction is selected from one or more mixtures of dichloromethane, dichloroethane, cyclohexane, methylcyclohexane, toluene, ethylbenzene, xylene, ethyl acetate, tetrahydrofuran or acetonitrile The preferred solvent is ethylene dichloride, hexanaphthene, methylcyclohexane, toluene, ethyl acetate or acetonitrile, and the usage amount is generally 2-10 times of corresponding general formula (I) raw material weight, preferably 3-8 times. Amidation also can use catalyzer 4-dimethylaminopyridine (DMAP), can shorten reaction time, but under preferred condition of the present invention, amidation need not use catalyzer and acid agent, and reaction yield and reaction time are all acceptable, so The present invention does not necessarily have to be used. Another raw material of amidation reaction, 4-heptafluoroisopropyl-2-trifluoromethylaniline, can be obtained through synthesis or market purchase. The synthetic method is made of o-trifluoromethylaniline raw material and 2-bromoheptafluoropropane or 2-iodoheptafluoropropane It is prepared by alkylation reaction in the presence of sodium hydrosulfite, and the synthesis details are disclosed in the Chinese invention patent CN 102119173B. The amount of raw material 4-heptafluoroisopropyl-2-trifluoromethylaniline is 1.0-1.3 times, preferably 1.0-1.05 times, the molar amount of the raw material of general formula (I). The bromination reaction uses liquid bromine as the bromination agent, which is cheap, the raw materials are easy to obtain, and the by-product bromide salt is easy to recycle. Compared with N-bromosuccinimide bromination agent, the cost is lower, and it is also conducive to environmental protection. 1-2 times the molar amount of the raw material of general formula (I), the preferred usage is 1-1.5 times, the preferred way of use is drip reaction, and the drip reaction can also be adopted under the condition of ultraviolet light, preferably without light, it can be carried out reaction.
溴化反应也可为降低溴的使用量,在反应后不久加入氧化剂,使得生成的溴化盐被氧化成单质溴再次被用于溴代反应,可以降低溴的使用量,但会带来反应体系的操作复杂及相关的副反应杂质,本发明不一定必须采用。The bromination reaction can also be used to reduce the amount of bromine, adding an oxidizing agent shortly after the reaction, so that the generated bromide salt is oxidized into elemental bromine and used again for the bromination reaction, which can reduce the amount of bromine used, but it will cause a reaction The complex operation of the system and related side reaction impurities are not necessarily used in the present invention.
溴化反应中的溶剂选自二氯甲烷、二氯乙烷、甲醇、乙醇、正丙醇、异丙醇、正丁醇、叔丁醇中的一种或多种混合物,优选使用溶剂为二氯乙烷、甲醇、乙醇、异丙醇、叔丁醇一种或多种混合物。使用量一般为对应通式(Ⅰ)原料重量的2-10倍,优选3-8倍。The solvent in the bromination reaction is selected from one or more mixtures in methylene dichloride, ethylene dichloride, methyl alcohol, ethanol, n-propanol, isopropanol, n-butanol, tert-butanol, and the preferred solvent is di One or more mixtures of ethyl chloride, methanol, ethanol, isopropanol, tert-butanol. The amount used is generally 2-10 times, preferably 3-8 times, the weight of the raw material corresponding to general formula (I).
溴化反应中的碱选自氢氧化钠、氢氧化钾、碳酸钾、碳酸钠或它们的任意浓度水溶液,或者使用任意浓度甲醇钠甲醇溶液、乙醇钠乙醇溶液、异丙醇钠异丙醇溶液、叔丁醇钠叔丁醇溶液,优选使用固体氢氧化钠、氢氧化钾、碳酸钾;使用量一般为通式(Ⅰ)原料摩尔量的1-2倍,优选使用量为1-1.5倍。溴化反应温度为0-100℃,优选使用温度为20-80℃。The alkali in the bromination reaction is selected from sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate or their aqueous solutions of any concentration, or use any concentration of sodium methylate methanol solution, sodium ethylate ethanol solution, sodium isopropoxide isopropanol solution , sodium tert-butoxide tert-butanol solution, preferably solid sodium hydroxide, potassium hydroxide, potassium carbonate; the usage amount is generally 1-2 times of the molar weight of the raw material of general formula (I), preferably the usage amount is 1-1.5 times . The bromination reaction temperature is 0-100°C, preferably the use temperature is 20-80°C.
在本发明中,优选地,R1取代基独立地选自H或氟;R2取代基独立地选自2-甲氧基乙基、2-乙氧基乙基、2-正丙氧基乙基、2-异丙氧基乙基、2-正丁氧基乙基、环丙基甲基、甲基或乙基;R3为甲基。In the present invention, preferably, the R substituents are independently selected from H or fluorine; the R substituents are independently selected from 2-methoxyethyl, 2-ethoxyethyl, 2-n-propoxy Ethyl, 2-isopropoxyethyl, 2-n-butoxyethyl, cyclopropylmethyl, methyl or ethyl; R 3 is methyl.
本发明还提供含七氟异丙基的双酰胺类化合物结晶体,当R1为H且R2为2-甲氧基乙基,所述结晶体x-射线粉末衍射在如下位置具有特征峰:The present invention also provides heptafluoroisopropyl-containing bisamide compound crystals. When R1 is H and R2 is 2-methoxyethyl, the crystal X-ray powder diffraction has characteristic peaks at the following positions:
2θ=3.521±0.2°、7.041±0.2°、8.238±0.2°、10.260±0.2°、10.578±0.2°、12.142±0.2°、12.941±0.2°、13.601±0.2°、14.922±0.2°、15.980±0.2°、17.417±0.2°、17.681±0.2°、18.321±0.2°、18.801±0.2°、19.241±0.2°、19.721±0.2°、20.420±0.2°、20.658±0.2°、21.218±0.2°、22.541±0.2°、23.379±0.2°、24.478±0.2°、24.898±0.2°、26.499±0.2°、27.420±0.2°、28.239±0.2°、29.461±0.2°、30.040±0.2°、30.839±0.2°、32.119±0.2°、32.318±0.2°、33.419±0.2°、33.741±0.2°、35.561±0.2°、37.720±0.2°。2θ=3.521±0.2°, 7.041±0.2°, 8.238±0.2°, 10.260±0.2°, 10.578±0.2°, 12.142±0.2°, 12.941±0.2°, 13.601±0.2°, 14.922±0.2°, 15.980±0.2 °, 17.417±0.2°, 17.681±0.2°, 18.321±0.2°, 18.801±0.2°, 19.241±0.2°, 19.721±0.2°, 20.420±0.2°, 20.658±0.2°, 21.218±0.2°, 22.541±0.2 °, 23.379±0.2°, 24.478±0.2°, 24.898±0.2°, 26.499±0.2°, 27.420±0.2°, 28.239±0.2°, 29.461±0.2°, 30.040±0.2°, 30.839±0.2°, 32.119±0.2 °, 32.318±0.2°, 33.419±0.2°, 33.741±0.2°, 35.561±0.2°, 37.720±0.2°.
当R1为氟且R2为2-甲氧基乙基,所述结晶体x-射线粉末衍射在如下位置具有特征峰:When R is fluorine and R is 2-methoxyethyl, the crystal x-ray powder diffraction has characteristic peaks at the following positions:
2θ=7.376±0.2°、9.897±0.2°、10.940±0.2°、12.015±0.2°、12.303±0.2°、14.398±0.2°、14.578±0.2°、15.561±0.2°、15.839±0.2°、17.163±0.2°、18.257±0.2°、18.463±0.2°、18.737±0.2°、18.922±0.2°、19.219±0.2°、19.518±0.2°、19.823±0.2°、20.137±0.2°、20.379±0.2°、20.600±0.2°、20.861±0.2°、21.023±0.2°、21.722±0.2°、22.021±0.2°、22.218±0.2°、22.818±0.2°、23.999±0.2°、24.738±0.2°、25.077±0.2°、25.481±0.2°、25.860±0.2°、27.161±0.2°、27.682±0.2°、29.058±0.2°、29.323±0.2°、29.760±0.2°、29.940±0.2°。2θ=7.376±0.2°, 9.897±0.2°, 10.940±0.2°, 12.015±0.2°, 12.303±0.2°, 14.398±0.2°, 14.578±0.2°, 15.561±0.2°, 15.839±0.2°, 17.163±0.2 °, 18.257±0.2°, 18.463±0.2°, 18.737±0.2°, 18.922±0.2°, 19.219±0.2°, 19.518±0.2°, 19.823±0.2°, 20.137±0.2°, 20.379±0.2°, 20.600±0.2 °, 20.861±0.2°, 21.023±0.2°, 21.722±0.2°, 22.021±0.2°, 22.218±0.2°, 22.818±0.2°, 23.999±0.2°, 24.738±0.2°, 25.077±0.2°, 25.481±0.2 °, 25.860±0.2°, 27.161±0.2°, 27.682±0.2°, 29.058±0.2°, 29.323±0.2°, 29.760±0.2°, 29.940±0.2°.
当R1为氟且R2为2-乙氧基乙基,结晶体x-射线粉末衍射在如下位置具有特征峰:When R is fluorine and R is 2 -ethoxyethyl, the crystal x-ray powder diffraction has characteristic peaks at the following positions:
2θ=7.318±0.2°、9.697±0.2°、10.940±0.2°、11.981±0.2°、12.136±0.2°、14.142±0.2°、14.461±0.2°、15.240±0.2°、15.561±0.2°、16.304±0.2°、17.161±0.2°、17.979±0.2°、18.562±0.2°、19.138±0.2°、19.698±0.2°、20.039±0.2°、20.220±0.2°、20.442±0.2°、20.784±0.2°、20.998±0.2°、21.819±0.2°、22.039±0.2°、22.401±0.2°、23.400±0.2°、23.882±0.2°、24.383±0.2°、24.579±0.2°、25.001±0.2°、25.160±0.2°、25.459±0.2°、26.780±0.2°、26.920±0.2°、27.199±0.2°、27.378±0.2°、28.742±0.2°、29.319±0.2°、29.998±0.2°、31.339±0.2°、31.939±0.2°、32.140±0.2°、32.522±0.2°、33.479±0.2°、36.400±0.2°、43.039±0.2°。2θ=7.318±0.2°, 9.697±0.2°, 10.940±0.2°, 11.981±0.2°, 12.136±0.2°, 14.142±0.2°, 14.461±0.2°, 15.240±0.2°, 15.561±0.2°, 16.304±0.2 °, 17.161±0.2°, 17.979±0.2°, 18.562±0.2°, 19.138±0.2°, 19.698±0.2°, 20.039±0.2°, 20.220±0.2°, 20.442±0.2°, 20.784±0.2°, 20.998±0.2 °, 21.819±0.2°, 22.039±0.2°, 22.401±0.2°, 23.400±0.2°, 23.882±0.2°, 24.383±0.2°, 24.579±0.2°, 25.001±0.2°, 25.160±0.2°, 25.459±0.2 °, 26.780±0.2°, 26.920±0.2°, 27.199±0.2°, 27.378±0.2°, 28.742±0.2°, 29.319±0.2°, 29.998±0.2°, 31.339±0.2°, 31.939±0.2°, 32.140±0.2 °, 32.522±0.2°, 33.479±0.2°, 36.400±0.2°, 43.039±0.2°.
在本发明中,所述结晶体是通过结晶溶剂结晶得到的,所述溶剂选自甲醇、乙醇、异丙醇、四氢呋喃、异丙醚、乙二醇单甲醚、乙二醇单乙醚、乙二醇二甲醚、乙二醇二乙醚、甲基叔丁基醚中的一种或多种混合物。In the present invention, the crystals are obtained by crystallization from a crystallization solvent, and the solvent is selected from methanol, ethanol, isopropanol, tetrahydrofuran, isopropyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol One or more mixtures of alcohol dimethyl ether, ethylene glycol diethyl ether, and methyl tert-butyl ether.
本发明得到的含七氟异丙基的双酰胺类化合物具有优异的杀虫活性,该化学反应条件温和,环境友好,总收率高,最终产品含量高,成本低,易于产业生产,具有很高的应用前景。The bisamide compound containing heptafluoroisopropyl group obtained in the present invention has excellent insecticidal activity, the chemical reaction conditions are mild, the environment is friendly, the total yield is high, the final product content is high, the cost is low, it is easy for industrial production, and has great advantages. high application prospects.
在本发明中,制备方法操作中涉及的蒸馏、减压蒸馏、过滤、干燥、萃取、分层、结晶、重结晶等操作为常规操作,再次不再详述。In the present invention, operations such as distillation, vacuum distillation, filtration, drying, extraction, layering, crystallization, and recrystallization involved in the preparation method operations are conventional operations, and will not be described in detail again.
【附图说明】【Description of drawings】
图1为合成实施例17的化合物样品经X-射线粉末晶体衍射分析结果;Fig. 1 is the result of X-ray powder crystal diffraction analysis of the compound sample of Synthesis Example 17;
图2为合成实施例18的化合物样品经X-射线粉末晶体衍射分析结果;Fig. 2 is the result of X-ray powder crystal diffraction analysis of the compound sample of Synthesis Example 18;
图3为合成实施例20的化合物样品经X-射线粉末晶体衍射分析结果。Fig. 3 is the X-ray powder crystal diffraction analysis result of the compound sample of Synthesis Example 20.
【具体实施方式】【Detailed ways】
以下实施例用于非限制性地解释本发明的技术方案,不应视为对本发明的具体限制。The following examples are used to explain the technical solutions of the present invention non-limitatively, and should not be regarded as specific limitations to the present invention.
本发明合成实施例中所述的原料,除特别说明外,一般为通过市场购买获取的,通常含量规格≥95%,含量没有精确校正,合成实施例中所述的百分比浓度除特别说明外,一般指重量百分比浓度,所述的HPLC含量数据为面积归一含量,没有精确校正,收率是指摩尔收率,收率数据也没有精确校正。The raw materials described in the synthesis examples of the present invention, unless otherwise specified, are generally purchased from the market, usually with a content specification ≥ 95%, and the content is not accurately corrected. Unless otherwise specified, the percentage concentrations described in the synthesis examples are Generally refers to the concentration by weight percentage, the HPLC content data is the area normalized content, without precise correction, and the yield refers to the molar yield, and the yield data is not precisely corrected.
合成准备实施例1Synthetic Preparation Example 1
在250ml的四口玻璃反应瓶中,投入甲醇100g,2-氟-3-硝基苯甲酸50g,98%硫酸2.5g,升温回流反应24小时,降温至0-5℃左右结晶,过滤,50℃烘干得到2-氟-3-硝基苯甲酸甲酯51g固体,HPLC含量98%,收率94.8%,用于合成反应。In a 250ml four-necked glass reaction flask, put methanol 100g, 2-fluoro-3-nitrobenzoic acid 50g, 98% sulfuric acid 2.5g, heat up and reflux for 24 hours, cool down to about 0-5°C to crystallize, filter, 50 Dry at °C to obtain 51 g of solid methyl 2-fluoro-3-nitrobenzoate, with an HPLC content of 98% and a yield of 94.8%, which was used for the synthesis reaction.
合成准备实施例2Synthetic Preparation Example 2
在250ml的四口玻璃反应瓶中,投入乙醇100g,2-氟-3-硝基苯甲酸50g,98%硫酸2.5g,升温回流反应24小时,降温至0-5℃左右结晶,过滤,50℃烘干得到2-氟-3-硝基苯甲酸乙酯54.5g固体,HPLC含量98%,收率94.6%,用于合成反应。In a 250ml four-necked glass reaction flask, put 100g of ethanol, 50g of 2-fluoro-3-nitrobenzoic acid, 2.5g of 98% sulfuric acid, heat up and reflux for 24 hours, cool down to about 0-5°C to crystallize, filter, 50 After drying at ℃, 54.5 g of ethyl 2-fluoro-3-nitrobenzoate was obtained as a solid, with an HPLC content of 98% and a yield of 94.6%, which was used for the synthesis reaction.
合成准备实施例3Synthetic Preparation Example 3
在500ml加氢反应釜中,投入甲醇250g,5%钯炭折干2g(含水量50%),投入合成准备实施例1得到的2-氟-3-硝基苯甲酸甲酯51g固体,密闭反应釜,氮气置换空气后,在用氢气置换两次氮气,在5-15℃维持压力0-0.05MPa通入氢气反应12小时,HPLC检测反应完成,取出,过滤掉催化剂(可回收套用),滤液减压脱溶,得到油状液体43g,为2-氟-3-氨基苯甲酸甲酯,HPLC含量97%,收率98.3%,用于合成反应。In a 500ml hydrogenation reactor, drop into methanol 250g, 5% palladium charcoal and dry 2g (
合成准备实施例4Synthetic Preparation Example 4
在500ml加氢反应釜中,投入甲醇250g,5%钯炭折干2g(含水量50%),投入合成准备实施例2得到的2-氟-3-硝基苯甲酸乙酯54.5g固体,密闭反应釜,氮气置换空气后,在用氢气置换两次氮气,在5-15℃维持压力0-0.05MPa通入氢气反应12小时,HPLC检测反应完成,取出,过滤掉催化剂(可回收套用),滤液减压脱溶,得到油状液体46g,为2-氟-3-氨基苯甲酸乙酯,HPLC归一含量96%,收率96.3%,用于合成反应。In the 500ml hydrogenation reactor, drop into methyl alcohol 250g, 5% palladium charcoal is dried 2g (
合成准备实施例5Synthetic Preparation Example 5
苯甲酸25g(0.20mol),氯化亚砜72g(0.60mol),升温回流反应2-5小时,降温至室温,反应液旋转蒸发,减压脱溶至80℃,得到苯甲酰氯油状液体,降温至25℃左右,加入新的二氯乙烷25g溶解备用。25g (0.20mol) of benzoic acid and 72g (0.60mol) of thionyl chloride were heated and refluxed for 2-5 hours, cooled to room temperature, the reaction solution was rotary evaporated, and the solvent was removed to 80°C under reduced pressure to obtain benzoyl chloride oily liquid. Cool down to about 25°C, add 25g of new dichloroethane to dissolve and set aside.
另一250ml的四口玻璃反应瓶中,投入二氯乙烷100g,3-氨基-2-氟苯甲酸甲酯35g(0.20mol),吡啶24g(0.30mol),冰浴降温至5-25℃,1小时内滴入上面苯甲酰氯备用液,5-25℃反应1-2小时,反应完成,加入水50ml,搅拌0.5小时,分层得到溶剂层,转移至500ml旋转蒸发器中,减压脱溶至80℃,得到2-氟-3-[(苯基羰基)氨基]苯甲酸甲酯米白色固体53g,HPLC归一含量94%(收率91.2%)备用,不做进一步处理直接用于合成反应。In another 250ml four-necked glass reaction bottle, put 100g of dichloroethane, 35g (0.20mol) of 3-amino-2-fluorobenzoic acid methyl ester, 24g (0.30mol) of pyridine, and cool down to 5-25°C in an ice bath , drop the above benzoyl chloride stock solution within 1 hour, react at 5-25°C for 1-2 hours, the reaction is completed, add 50ml of water, stir for 0.5 hours, separate layers to obtain a solvent layer, transfer to a 500ml rotary evaporator, and reduce pressure Precipitate to 80°C to obtain 53 g of off-white solid of methyl 2-fluoro-3-[(phenylcarbonyl)amino]benzoate, HPLC normalized content 94% (yield 91.2%) for later use, without further processing in the synthesis reaction.
合成准备实施例6Synthetic Preparation Example 6
按照合成准备实施例5相似操作,其中3-氨基-2-氟苯甲酸甲酯35g(0.20mol)原料用合成准备实施例4所得3-氨基-2-氟苯甲酸乙酯38g(0.20mol)代替,其他不变,最后得到2-氟-3-[(苯基羰基)氨基]苯甲酸乙酯米白色固体55g,HPLC归一含量94%(收率90%)备用,不做进一步处理直接用于合成反应。According to the similar operation of synthesis preparation example 5, wherein 3-amino-2-fluorobenzoic acid methyl ester 35g (0.20mol) raw material is 3-amino-2-fluorobenzoic acid ethyl ester 38g (0.20mol) obtained in synthesis preparation example 4 Replacement, other unchanged, finally obtained 2-fluoro-3-[(phenylcarbonyl)amino]ethyl benzoate off-white solid 55g, HPLC normalized content 94% (yield 90%) standby, do not do further processing directly for synthesis reactions.
合成准备实施例7Synthetic Preparation Example 7
按照合成准备实施例5操作,苯甲酸25g(0.20mol)用对氟苯甲酸28g(0.20mol)代替,其他操作相同,最后得到2-氟-3-[(4-氟苯基羰基)氨基]苯甲酸甲酯米白色固体56g,HPLC归一含量94%(收率90.2%)备用,不做进一步处理直接用于合成反应。According to the synthesis preparation example 5, 25g (0.20mol) of benzoic acid was replaced by 28g (0.20mol) of p-fluorobenzoic acid, and the other operations were the same, and finally 2-fluoro-3-[(4-fluorophenylcarbonyl)amino] was obtained Methyl benzoate was 56 g of off-white solid, with HPLC normalized content of 94% (yield 90.2%) for later use, and was directly used in the synthesis reaction without further treatment.
合成实施例1Synthesis Example 1
2-氟-3-[(2-甲氧乙基)(苯基羰基)氨基]苯甲酸的合成。Synthesis of 2-fluoro-3-[(2-methoxyethyl)(phenylcarbonyl)amino]benzoic acid.
在250ml的四口玻璃反应瓶中,投入溶剂N,N-二甲基甲酰胺200g,碱碳酸钾15g(0.10mol),再投入合成准备实施例5合成得到的2-氟-3-[(苯基羰基)氨基]苯甲酸甲酯物料25g(0.086mol),催化剂四丁基溴化铵1g,升温至55-65℃,1小时内滴入1-溴-2-甲氧基乙烷15.8g(0.11mol),保温反应2小时左右,水降温至室温,过滤,滤液减压脱溶,得到残余物料,加入甲醇50g,10%液碱60g(0.15mol),升温25-35℃,保温反应2小时左右,加入水150g,30%盐酸调节pH为1-2,10-25℃左右结晶,过滤、水洗,烘干得到26.5g米白色固体,熔点:155.8-157.9℃,HPLC归一含量95%左右,收率92.3%,为2-氟-3-[(2-甲氧乙基)(苯基羰基)氨基]苯甲酸。反应式如下:In a 250ml four-necked glass reaction flask, add solvent N,N-dimethylformamide 200g, alkali potassium carbonate 15g (0.10mol), then drop into the 2-fluoro-3-[( Phenylcarbonyl)amino]methyl benzoate material 25g (0.086mol), catalyst tetrabutylammonium bromide 1g, warming up to 55-65°C, drop 1-bromo-2-methoxyethane 15.8 g in 1 hour g (0.11mol), heat preservation reaction for about 2 hours, cool the water to room temperature, filter, and desolvate the filtrate under reduced pressure to obtain the residual material, add
合成实施例2-4Synthesis Example 2-4
按照合成实施例1的操作,催化剂四丁基溴化铵1g,分别用四丁基氯化铵1g、四丁基硫酸氢铵1g、18-冠-6-醚1g代替,其他投料及操作不变,得到的结果相近。According to the operation of Synthesis Example 1, the catalyst tetrabutylammonium bromide 1g is replaced with tetrabutylammonium chloride 1g, tetrabutylammonium bisulfate 1g, 18-crown-6-ether 1g respectively, and other materials and operations are not changed. changed, the results were similar.
合成实施例5Synthesis Example 5
在250ml的四口玻璃反应瓶中,投入溶剂甲苯100g,投入碱碳酸钾15g(0.10mol),投入合成准备实施例5合成得到的2-氟-3-[(苯基羰基)氨基]苯甲酸甲酯物料25g(0.086mol),催化剂四丁基溴化铵1g,加入1-溴-2-甲氧基乙烷15.8g(0.11mol),装上回流分水器,升温至回流反应,脱出反应生成水,回流反应约2小时左右,至无水生成,水降温至室温,过滤,滤液减压脱溶,得到残余料,加入甲醇50g,10%液碱60g(0.15mol),升温25-35℃,保温反应2小时左右,加入水150g,30%盐酸调节pH为1-2,10-25℃左右结晶,过滤、水洗,烘干得到27g米白色固体,HPLC归一含量95%左右,收率94%,为2-氟-3-[(2-甲氧乙基)(苯基羰基)氨基]苯甲酸。In a 250ml four-necked glass reaction flask, drop into solvent toluene 100g, drop into alkali potassium carbonate 15g (0.10mol), drop into the 2-fluoro-3-[(phenylcarbonyl) amino] benzoic acid that synthetic preparation embodiment 5 synthesis obtains 25g (0.086mol) of methyl ester material, 1g of catalyst tetrabutylammonium bromide, 15.8g (0.11mol) of 1-bromo-2-methoxyethane was added, the reflux water separator was installed, the temperature was raised to reflux reaction, and the The reaction generates water, and the reflux reaction is about 2 hours until anhydrous is formed, the water is cooled to room temperature, filtered, the filtrate is desolvated under reduced pressure, and the residue is obtained. Add
合成实施例6-7Synthesis Example 6-7
按照合成实施例5的操作,溶剂甲苯100g,分别用甲基环己烷100g、二甲苯100g代替,其他投料及操作不变,得到的结果相近。According to the operation of Synthesis Example 5, 100 g of solvent toluene was replaced by 100 g of methylcyclohexane and 100 g of xylene respectively, and the other materials and operations were unchanged, and the obtained results were similar.
合成实施例8Synthesis Example 8
2-氟-3-[(2-乙氧乙基)(4-氟苯基羰基)氨基]苯甲酸的合成。Synthesis of 2-fluoro-3-[(2-ethoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid.
在一250ml的四口玻璃反应瓶中,投入溶剂二氯乙烷100g,4-氟苯甲酸12.5g(0.088mol),氯化亚砜25g(0.20mol),升温回流反应2-5小时,减压脱溶得到油状液体为4-氟苯甲酰氯,待用。In a 250ml four-necked glass reaction flask, drop into solvent dichloroethane 100g, 4-fluorobenzoic acid 12.5g (0.088mol), thionyl chloride 25g (0.20mol), heat up and reflux for 2-5 hours, reduce The oily liquid obtained by pressure precipitation is 4-fluorobenzoyl chloride, which is ready for use.
在另一250ml的四口玻璃反应瓶中,投入溶剂N,N-二甲基甲酰胺200g,氮气保护,投入碱60%氢化钠3.5g(0.091mol),再投入合成准备实施例3合成得到的2-氟-3-氨基苯甲酸甲酯15g(0.086mol),催化剂四丁基溴化铵1g,加入1-溴-2-乙氧基乙烷16.8g(0.11mol),升温至110-120℃,保温反应8小时左右,水降温至室温,过滤后,滤液减压脱溶,残余物料加入二氯乙烷100ml萃取、水洗涤(产物核磁氢谱、质谱数据附后),溶剂层用无水硫酸镁干燥过滤得到的滤液在25-35℃,加入上面合成得到的4-氟苯甲酰氯,升温至回流反应2-5小时,减压脱溶,得到残余油状物料(产物核磁氢谱、质谱数据附后),加入甲醇50g,10%液碱60g(0.15mol),升温25-35℃,保温反应2小时左右,加入水150g,30%盐酸调节pH为1-2,10-25℃左右结晶,过滤、水洗,烘干得到29.4g米黄色固体,熔点:77.3-79.2℃,HPLC归一含量92%左右,收率90.1%,为2-氟-3-[(2-乙氧乙基)(苯基羰基)氨基]苯甲酸(产物的核磁氢谱、质谱数据附后)。反应式如下:In another 250ml four-necked glass reaction bottle, put in 200g of N,N-dimethylformamide as a solvent, protect it under nitrogen, put in 3.5g (0.091mol) of alkali 60% sodium hydride, and then put it into synthesis preparation Example 3 to synthesize 15g (0.086mol) of methyl 2-fluoro-3-aminobenzoate, catalyst tetrabutylammonium bromide 1g, add 16.8g (0.11mol) of 1-bromo-2-ethoxyethane, and heat up to 110- 120°C, heat preservation reaction for about 8 hours, cool the water to room temperature, filter, and precipitate the filtrate under reduced pressure, add 100ml of dichloroethane to extract the residual material, wash with water (the H NMR spectrum and mass spectrum data of the product are attached), use the solvent layer The filtrate obtained by drying and filtering over anhydrous magnesium sulfate was added at 25-35°C with the 4-fluorobenzoyl chloride synthesized above, heated to reflux for 2-5 hours, and desolvated under reduced pressure to obtain the residual oily material (product NMR , mass spectrum data attached), add methanol 50g, 10% liquid caustic soda 60g (0.15mol), heat up 25-35 ℃, heat preservation reaction for about 2 hours, add water 150g, 30% hydrochloric acid to adjust the pH to 1-2, 10-25 Crystallize at about ℃, filter, wash with water, and dry to obtain 29.4g beige solid, melting point: 77.3-79.2℃, HPLC normalized content about 92%, yield 90.1%. It is 2-fluoro-3-[(2-ethoxy Ethyl)(phenylcarbonyl)amino]benzoic acid (the H NMR spectrum and mass spectrometry data of the product are attached). The reaction formula is as follows:
核磁氢谱使用Bruker AV-400spectrometer(400MHz),TMS作为内标,溶剂使用CDCl3 or DMSO-d6(如无特别说明,下同);高分辨率质谱使用UHR-TOF maXis(ESI)质谱仪测定(如无特别说明,下同)。The H NMR spectrum was measured using Bruker AV-400spectrometer (400MHz), TMS was used as an internal standard, and the solvent was CDCl 3 or DMSO-d6 (unless otherwise specified, the same below); the high-resolution mass spectrum was measured using a UHR-TOF maXis (ESI) mass spectrometer (Unless otherwise specified, the same below).
2-氟-3-[(2-乙氧乙基)氨基]苯甲酸甲酯的核磁氢谱、质谱数据如下:2-Fluoro-3-[(2-ethoxyethyl)amino]benzoic acid methyl ester proton magnetic spectrum, mass spectral data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):7.10-6.90(m,3H,ArH),5.49(s,1H,NH),3.80(s,3H,CH3O),3.50(t,J=6.0Hz,2H,OCH2),3.41(q,J=6.2Hz,2H,OCH2CH3),3.25(dd,J1=J2=6.0Hz,2H,NCH2),1.08(t,J=6.8Hz,3H,OCH2CH3)。 1 H-NMR(400MHz,DMSO-d6)δ(ppm):7.10-6.90(m,3H,ArH),5.49(s,1H,NH),3.80(s,3H,CH3O),3.50(t,J =6.0Hz,2H,OCH2),3.41(q,J=6.2Hz,2H,OCH2CH3),3.25(dd,J1=J2=6.0Hz,2H,NCH2),1.08(t,J=6.8Hz,3H, OCH2CH3).
HRMS(ESI)calcd.for C12H16FNNaO3[(M+Na)+]:264.1012;Found:264.0988。HRMS (ESI) calcd. for C 12 H 16 FNNaO 3 [(M+Na)+]: 264.1012; Found: 264.0988.
2-氟-3-(4-氟-N-(2-乙氧乙基)苯甲酰氨基)苯甲酸甲酯的核磁氢谱、质谱数据如下:2-Fluoro-3-(4-fluoro-N-(2-ethoxyethyl) benzamido) methyl benzoate H NMR spectrum, mass spectrometry data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):7.78-7.70(m,2H,ArH),7.48-7.20(m,3H,ArH),7.18-6.90(m,2H,ArH),4.10-3.80(m,2H,OCH2),3.75(s,3H,CH3O),3.65-3.40(m,2H,NCH2),3.28(q,J=6.2Hz,2H,OCH2CH3),0.92(t,J=6.8Hz,3H,OCH2CH3)。 1 H-NMR(400MHz,DMSO-d6)δ(ppm):7.78-7.70(m,2H,ArH),7.48-7.20(m,3H,ArH),7.18-6.90(m,2H,ArH),4.10 -3.80(m,2H,OCH2),3.75(s,3H,CH3O),3.65-3.40(m,2H,NCH2),3.28(q,J=6.2Hz,2H,OCH2CH3),0.92(t,J= 6.8Hz, 3H, OCH2CH3).
HRMS(ESI)calcd.for C19H19F2NNaO4[(M+Na)+]:386.1180;Found:386.1173。HRMS (ESI) calcd. for C 19 H 19 F 2 NNaO 4 [(M+Na)+]: 386.1180; Found: 386.1173.
2-氟-3-[(2-乙氧乙基)(苯基羰基)氨基]苯甲酸的核磁氢谱、质谱数据如下:2-Fluoro-3-[(2-ethoxyethyl)(phenylcarbonyl)amino]benzoic acid has the following H NMR and mass spectrometry data:
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.20(s,1H,COOH),7.75-7.60(m,2H,ArH),7.38-7.15(m,3H,ArH),7.12-6.90(m,2H,ArH),4.10-3.82(m,2H,OCH2),3.68-3.49(m,2H,NCH2),3.30(q,J=6.2Hz,2H,OCH2CH3),0.94(t,J=6.8Hz,3H,OCH2CH3)。 1 H-NMR(400MHz,DMSO-d6)δ(ppm):10.20(s,1H,COOH),7.75-7.60(m,2H,ArH),7.38-7.15(m,3H,ArH),7.12-6.90 (m,2H,ArH),4.10-3.82(m,2H,OCH2),3.68-3.49(m,2H,NCH2),3.30(q,J=6.2Hz,2H,OCH2CH3),0.94(t,J= 6.8Hz, 3H, OCH2CH3).
HRMS(ESI)calcd.for C18H17F2NNaO4[(M+Na)+]:372.1023;Found:372.1024。HRMS (ESI) calcd. for C 18 H 17 F 2 NNaO 4 [(M+Na)+]: 372.1023; Found: 372.1024.
合成实施例9Synthesis Example 9
按照合成实施例8的操作,第二步酰胺化时加入4-二甲氨基吡啶(DMAP)1g,其他投料及操作不变,得到的结果相近。According to the operation of Synthesis Example 8, 1 g of 4-dimethylaminopyridine (DMAP) was added in the second step of amidation, and the other materials and operations were unchanged, and the obtained results were similar.
合成实施例10Synthesis Example 10
2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸的合成。Synthesis of 2-fluoro-3-[(2-methoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid.
在一250ml的四口玻璃反应瓶中,投入溶剂二氯乙烷100g,对氟苯甲酸12.5g(0.088mol),氯化亚砜25g(0.20mol),升温回流反应2-5小时,减压脱溶得到油状液体为对氟苯甲酰氯,待用。In a 250ml four-necked glass reaction flask, put 100g of dichloroethane as solvent, 12.5g (0.088mol) of p-fluorobenzoic acid, 25g (0.20mol) of thionyl chloride, heat up and reflux for 2-5 hours, and depressurize The oily liquid obtained by precipitation is p-fluorobenzoyl chloride, which is ready for use.
在另一250ml的四口玻璃反应瓶中,投入溶剂甲苯100g,投入碱碳酸钾15g(0.10mol),投入合成准备实施例3合成得到的2-氟-3-氨基苯甲酸甲酯15g(0.086mol),催化剂四丁基溴化铵1g,加入1-溴-2-甲氧基乙烷15.8g(0.11mol),升温至100-120℃,回流脱水反应,约5小时左右,水降温至室温,过滤,水洗、减压脱溶得到物料(产物核磁氢谱、质谱数据附后)加入二氯乙烷100g溶解,在25-35℃,加入上面合成得到的对氟苯甲酰氯,升温回流反应2-5小时。降温加水100ml,分层、洗涤,减压脱溶,得到残余油状物料(产物核磁氢谱、质谱数据附后),加入甲醇50g,10%液碱60g(0.15mol),升温25-35℃,保温反应2小时左右,加入水150g,30%盐酸调节pH为1-2,10-25℃左右结晶,过滤、水洗,烘干得到28g米黄色固体,熔点:120.5-122.5℃,HPLC归一含量93%左右,收率90.3%,为2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸(产物核磁氢谱、质谱数据附后)。反应式如下:In another 250ml four-necked glass reaction flask, drop into solvent toluene 100g, drop into alkali potassium carbonate 15g (0.10mol), drop into the 2-fluoro-3-aminobenzoic acid methyl ester 15g (0.086 mol), catalyst tetrabutylammonium bromide 1g, add 1-bromo-2-methoxyethane 15.8g (0.11mol), heat up to 100-120°C, reflux dehydration reaction, about 5 hours, water cooling to At room temperature, filter, wash with water, and desolvate under reduced pressure to obtain the material (product NMR, mass spectrometry data is attached) and add 100 g of dichloroethane to dissolve it. At 25-35 ° C, add the p-fluorobenzoyl chloride synthesized above, and heat up to reflux React for 2-5 hours. Cool down and add 100ml of water, separate layers, wash, and desolvate under reduced pressure to obtain residual oily material (product NMR, mass spectrometry data are attached), add
2-氟-3-[(2-甲氧乙基)氨基]苯甲酸甲酯的核磁氢谱、质谱数据如下:2-Fluoro-3-[(2-methoxyethyl)amino]benzoic acid methyl ester proton magnetic spectrum, mass spectral data are as follows:
1H-NMR(400MHz,CDCl3)δ(ppm):7.00-6.91(m,3H,ArH),5.50(s,1H,NH),3.80(s,3H,OCH3),4.45(t,J=3.9Hz,2H,OCH2),3.25-7.24(m,5H,NCH2 and OCH3)。 1 H-NMR (400MHz, CDCl3) δ (ppm): 7.00-6.91 (m, 3H, ArH), 5.50 (s, 1H, NH), 3.80 (s, 3H, OCH3), 4.45 (t, J = 3.9 Hz, 2H, OCH2), 3.25-7.24 (m, 5H, NCH2 and OCH3).
HRMS(ESI)calcd.for C11H14FNNaO3[(M+Na)+]:250.0855;Found:250.0836。HRMS (ESI) calcd. for C 11 H 14 FNNaO 3 [(M+Na)+]: 250.0855; Found: 250.0836.
2-氟-3-(4-氟-N-(2-甲氧乙基)苯甲酰氨基)苯甲酸甲酯的核磁氢谱、质谱数据如下:2-Fluoro-3-(4-fluoro-N-(2-methoxyethyl) benzamido) methyl benzoate H NMR spectrum, mass spectrometry data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):7.74-7.71(m,2H,ArH),7.48-7.20(m,3H,ArH),7.18-6.80(m,2H,ArH),4.20-3.80(m,2H,OCH2),3.79(s,3H,CH3O),3.62-3.40(m,2H,NCH2),3.13(s,3H,CH3O)。HRMS(ESI)calcd.for C18H17F2NNaO4[(M+Na)+]:372.1023;Found:372.1024。 1 H-NMR(400MHz,DMSO-d6)δ(ppm):7.74-7.71(m,2H,ArH),7.48-7.20(m,3H,ArH),7.18-6.80(m,2H,ArH),4.20 -3.80 (m, 2H, OCH2), 3.79 (s, 3H, CH3O), 3.62-3.40 (m, 2H, NCH2), 3.13 (s, 3H, CH3O). HRMS (ESI) calcd. for C 18 H 17 F 2 NNaO 4 [(M+Na)+]: 372.1023; Found: 372.1024.
2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸的核磁氢谱、质谱数据如下:2-Fluoro-3-[(2-methoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid has the following H NMR and mass spectrometry data:
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.32(s,1H,COOH),7.70-7.60(m,2H,ArH),7.38-7.20(m,3H,ArH),7.15-6.90(m,2H,ArH),4.15-3.82(m,2H,OCH2),3.53-3.40(m,2H,NCH2),3.14(s,3H,OCH3)。 1 H-NMR(400MHz,DMSO-d6)δ(ppm):10.32(s,1H,COOH),7.70-7.60(m,2H,ArH),7.38-7.20(m,3H,ArH),7.15-6.90 (m, 2H, ArH), 4.15-3.82 (m, 2H, OCH2), 3.53-3.40 (m, 2H, NCH2), 3.14 (s, 3H, OCH3).
HRMS(ESI)calcd.for C17H15F2NNaO4[(M+Na)+]:358.0867;Found:358.0858。HRMS (ESI) calcd. for C 17 H 15 F 2 NNaO 4 [(M+Na)+]: 358.0867; Found: 358.0858.
合成实施例11Synthetic Example 11
2-氟-3-[(甲基)(苯基羰基)氨基]苯甲酸的合成。Synthesis of 2-fluoro-3-[(methyl)(phenylcarbonyl)amino]benzoic acid.
在500ml的压力反应釜中,投入溶剂N,N-二甲基甲酰胺200g,投入碱碳酸钾15g(0.10mol),投入合成准备实施例5合成得到的2-氟-3-[(苯基羰基)氨基]苯甲酸甲酯物料25g(0.086mol),催化剂四丁基溴化铵1g,室温通入溴甲烷20g(0.21mol),密闭反应釜,升温至55-65℃,保温反应2小时左右,降温至室温,过滤,滤液减压脱溶得油状液体,加入甲醇50g,10%液碱60g(0.15mol),升温25-35℃,保温反应2小时左右,加入水150g,30%盐酸调节pH为1-2,10-25℃左右结晶,过滤、水洗,烘干得到23g米白色固体,HPLC归一含量95%左右,收率93%,为2-氟-3-[(甲基)(苯基羰基)氨基]苯甲酸。反应式如下:In a 500ml pressure reactor, put in 200g of solvent N,N-dimethylformamide, drop in 15g (0.10mol) of alkali potassium carbonate, and put in the 2-fluoro-3-[(phenyl Carbonyl)amino]methyl benzoate material 25g (0.086mol), catalyst tetrabutylammonium bromide 1g, bromide 20g (0.21mol) at room temperature, airtight reaction kettle, heat up to 55-65°C, heat preservation reaction for about 2 hours , cooled to room temperature, filtered, and the filtrate was desolvated under reduced pressure to obtain an oily liquid, added 50g of methanol, 60g (0.15mol) of 10% liquid caustic soda, raised the temperature to 25-35°C, kept the temperature for about 2 hours, added 150g of water, 30% hydrochloric acid to adjust pH is 1-2, crystallized at around 10-25°C, filtered, washed with water, dried to obtain 23g off-white solid, HPLC normalized content about 95%, yield 93%, is 2-fluoro-3-[(methyl) (Phenylcarbonyl)amino]benzoic acid. The reaction formula is as follows:
合成实施例12Synthetic Example 12
按照合成实施例11操作,溴甲烷20g(0.21mol)用溴乙烷22g(0.20mol)代替,加入压力釜,其他操作相似,最后得到24g米白色固体,HPLC归一含量95%左右,收率92.3%,为2-氟-3-[(乙基)(苯基羰基)氨基]苯甲酸。反应式如下:According to the operation of Synthesis Example 11, 20 g (0.21 mol) of methyl bromide was replaced by 22 g (0.20 mol) of ethyl bromide, and added to an autoclave. The other operations were similar, and finally 24 g of off-white solid was obtained. The HPLC normalized content was about 95%, and the yield was 92.3 %, 2-fluoro-3-[(ethyl)(phenylcarbonyl)amino]benzoic acid. The reaction formula is as follows:
合成实施例13Synthetic Example 13
在250ml的四口玻璃反应瓶中,投入溶剂甲苯100g,投入碱碳酸钾15g(0.10mol),投入合成准备实施例7合成得到的2-氟-3-[(4-氟苯基羰基)氨基]苯甲酸甲酯物料26.7g(0.086mol),催化剂四丁基溴化铵1g,加入1-溴-2-甲氧基乙烷15.8g(0.11mol),装上回流分水器,升温至回流反应,脱出反应生成水,回流反应约2小时左右,至无水生成,水降温至室温,过滤,减压脱溶,得到残余料,加入甲醇50g,10%液碱60g(0.15mol),升温25-35℃,保温反应2小时左右,加入水150g,30%盐酸调节pH为1-2,10-25℃左右结晶,过滤、水洗,烘干得到28.5g米黄色固体,熔点:122.5-123.4℃,HPLC归一含量95%左右,收率93.9%,为2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸。反应式及产物的核磁氢谱、质谱数据如下:In a 250ml four-necked glass reaction flask, drop in 100g of solvent toluene, drop in 15g (0.10mol) of alkali potassium carbonate, and drop in the 2-fluoro-3-[(4-fluorophenylcarbonyl)amino synthesized in Preparation Example 7 ] methyl benzoate material 26.7g (0.086mol), catalyzer tetrabutylammonium bromide 1g, add 1-bromo-2-methoxyethane 15.8g (0.11mol), load back flow separator, be warming up to Reflux reaction, removal of reaction to generate water, reflux reaction for about 2 hours, until anhydrous is generated, water is cooled to room temperature, filtered, desolvated under reduced pressure, to obtain residual material, add
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.32(s,1H,COOH),7.70-7.60(m,2H,ArH),7.38-7.20(m,3H,ArH),7.15-6.90(m,2H,ArH),4.15-3.82(m,2H,OCH2),3.53-3.40(m,2H,NCH2),3.14(s,3H,OCH3)。HRMS(ESI)calcd.for C17H15F2NNaO4[(M+Na)+]:358.0867;Found:358.0858。 1 H-NMR(400MHz,DMSO-d6)δ(ppm):10.32(s,1H,COOH),7.70-7.60(m,2H,ArH),7.38-7.20(m,3H,ArH),7.15-6.90 (m, 2H, ArH), 4.15-3.82 (m, 2H, OCH2), 3.53-3.40 (m, 2H, NCH2), 3.14 (s, 3H, OCH3). HRMS (ESI) calcd. for C 17 H 15 F 2 NNaO 4 [(M+Na)+]: 358.0867; Found: 358.0858.
合成实施例14Synthetic Example 14
按照合成实施例13操作,1-溴-2-甲氧基乙烷15.8g(0.11mol)用溴甲基环丙烷16.5g(0.12mol)代替,其他操作相同,最后得到28g米白色固体,HPLC归一含量95%左右,收率93.3%,为2-氟-3-[(环丙基甲基)(4-氟苯基羰基)氨基]苯甲酸。According to the operation of Synthesis Example 13, 15.8g (0.11mol) of 1-bromo-2-methoxyethane was replaced by 16.5g (0.12mol) of bromomethylcyclopropane, and the other operations were the same, and finally 28g off-white solid was obtained, HPLC The normalized content is about 95%, and the yield is 93.3%. It is 2-fluoro-3-[(cyclopropylmethyl)(4-fluorophenylcarbonyl)amino]benzoic acid.
合成实施例15-16Synthetic Examples 15-16
分别按照合成实施例1及合成实施例5操作,2-氟-3-[(苯基羰基)氨基]苯甲酸甲酯物料25g(0.086mol)用合成准备实施例6所得2-氟-3-[(苯基羰基)氨基]苯甲酸乙酯26.3g(0.086mol)代替,其他操作相同,得到的结果相近。According to the operation of Synthesis Example 1 and Synthesis Example 5 respectively, 25 g (0.086 mol) of 2-fluoro-3-[(phenylcarbonyl) amino]methyl benzoate material was prepared from the 2-fluoro-3- [(phenylcarbonyl)amino]benzoic acid ethyl ester 26.3g (0.086mol) was replaced, other operations were the same, and the results obtained were similar.
合成对比实施例1Synthetic Comparative Example 1
按照合成实施例1,其中催化剂四丁基溴化铵1g不加,其他的投料及操作全部相同,最后得到24g米白色固体,目标产物2-氟-3-[(2-甲氧乙基)(苯基羰基)氨基]苯甲酸HPLC归一含量55%左右,收率48.3%,其他主要为2-氟-3-[(苯基羰基)氨基]苯甲酸。According to Synthesis Example 1, wherein the catalyst tetrabutylammonium bromide 1g is not added, other materials and operations are all the same, and finally 24g off-white solid is obtained, the target product 2-fluoro-3-[(2-methoxyethyl) (Phenylcarbonyl)amino]benzoic acid HPLC normalized content is about 55%, the yield is 48.3%, and the others are mainly 2-fluoro-3-[(phenylcarbonyl)amino]benzoic acid.
合成对比实施例2Synthetic Comparative Example 2
按照合成实施例5,其中催化剂四丁基溴化铵1g不加,其他的投料及操作全部相同,最后得到21g米白色固体,目标产物2-氟-3-[(2-甲氧乙基)(苯基羰基)氨基]苯甲酸HPLC归一含量5%左右,收率3.8%,其他主要为2-氟-3-[(苯基羰基)氨基]苯甲酸。According to Synthesis Example 5, wherein the catalyst tetrabutylammonium bromide 1g is not added, other materials and operations are all the same, and finally 21g off-white solid is obtained, the target product 2-fluoro-3-[(2-methoxyethyl) (Phenylcarbonyl)amino]benzoic acid HPLC normalized content of about 5%, yield 3.8%, the other is mainly 2-fluoro-3-[(phenylcarbonyl)amino]benzoic acid.
合成对比实施例3Synthetic Comparative Example 3
按照合成实施例8的操作,其中催化剂四丁基溴化铵1g不加,其他的投料及操作全部相同,最后得到油状物料归一含量45%左右,没有得到目标产物固体结晶。According to the operation of Synthesis Example 8, wherein catalyst tetrabutylammonium bromide 1g was not added, other feeding and operations were all the same, and finally the oily material was obtained with a normalized content of about 45%, and no solid crystal of the target product was obtained.
合成实施例17Synthetic Example 17
2-氟-3-[(苯基羰基)(2-甲氧乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-Fluoro-3-[(phenylcarbonyl)(2-methoxyethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropane-2 -Synthetic preparation of -6-(trifluoromethyl)phenyl]benzamide.
250ml的四口玻璃反应瓶中,投入二氯乙烷200g,合成实施例1得到的2-氟-3-[(2-甲氧乙基)(苯基羰基)氨基]苯甲酸23.7g(0.071mol),氯化亚砜24g(0.20mol),升温回流反应3-5小时,降温至室温,反应液转移至500ml旋转蒸发器中,减压脱溶至80℃,得到酰氯油状液体,降温至25℃左右,加入乙腈150g溶解,转移至反应瓶中,并加入4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-2-(三氟甲基)苯胺原料27.8g(0.08mol),升温回流反应5-10小时。In the four-necked glass reaction bottle of 250ml, drop into dichloroethane 200g, the 2-fluoro-3-[(2-methoxyethyl) (phenylcarbonyl) amino] benzoic acid 23.7g (0.071 mol), thionyl chloride 24g (0.20mol), heated and refluxed for 3-5 hours, cooled to room temperature, the reaction solution was transferred to a 500ml rotary evaporator, and desolvated to 80°C under reduced pressure to obtain an acid chloride oily liquid, which was cooled to At about 25°C, add 150g of acetonitrile to dissolve, transfer to the reaction bottle, and add 4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-(trifluoromethyl)aniline 27.8 g (0.08 mol) of the raw material was heated and refluxed for 5-10 hours.
降温至室温,加入粉状碳酸钾20g,在25-45℃,2小时左右滴入液溴13.5g反应,保温2小时,过滤,滤去无机盐,滤液减压脱溶,得到残余料,加入乙醇120g,升温回流1小时,降温结晶,在0-5℃结晶1小时,过滤干燥得到白色结晶粉末固体42g,为目标化合物,熔点:179.5-180.5℃,HPLC归一含量98%左右,三步总收率81.9%。反应式如下:Cool down to room temperature, add 20g of powdered potassium carbonate, drop in 13.5g of liquid bromine at 25-45°C for about 2 hours to react, keep warm for 2 hours, filter, filter out inorganic salts, and desolvate the filtrate under reduced pressure to obtain the residual material, add Ethanol 120g, heat up and reflux for 1 hour, cool down to crystallize, crystallize at 0-5°C for 1 hour, filter and dry to obtain 42g of white crystalline powder solid, which is the target compound, melting point: 179.5-180.5°C, HPLC normalized content about 98%, three steps The total yield is 81.9%. The reaction formula is as follows:
核磁氢谱、质谱数据如下:The H NMR and mass spectrometry data are as follows:
核磁氢谱使用Bruker AV-400spectrometer(400MHz),TMS作为内标,溶剂使用DMSO-d6(如无特别说明,下同);高分辨率质谱使用UHR-TOF maXis(ESI)质谱仪测定(如无特别说明,下同)。The proton nuclear magnetic spectrum uses Bruker AV-400spectrometer (400MHz), TMS is used as internal standard, the solvent uses DMSO-d6 (if no special instructions, the same below); high resolution mass spectrum is measured using UHR-TOF maXis (ESI) mass spectrometer (if no Special instructions, the same below).
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.57(s,1H,CONH),8.39(s,1H),7.92(s,1H),7.61-7.51(m,3H),7.34-7.24(m,5H),4.32-3.70(m,2H),3.68-3.45(m,2H),3.19(s,3H)。 1 H-NMR (400MHz, DMSO-d6) δ (ppm): 10.57 (s, 1H, CONH), 8.39 (s, 1H), 7.92 (s, 1H), 7.61-7.51 (m, 3H), 7.34- 7.24 (m, 5H), 4.32-3.70 (m, 2H), 3.68-3.45 (m, 2H), 3.19 (s, 3H).
HRMS(ESI)calcd.for C27H18BrF11N2NaO3[(M+Na)+]:729.0223[(M+Na)+],731.0202[(M+2+Na)+];Found:729.0213[(M+Na)+],731.0196[(M+2+Na)+]。HRMS(ESI)calcd.for C 27 H 18 BrF 11 N 2 NaO 3 [(M+Na) + ]: 729.0223[(M+Na) + ], 731.0202[(M+2+Na) + ]; Found: 729.0213[(M+Na) + ], 731.0196[(M+2+Na) + ].
目标化合物样品经X-射线粉末晶体衍射分析,仪器使用日本理学SmartLab衍射仪分析(如无特别说明,下同),结晶体在如下位置有特征峰,2θ=3.521±0.2°、7.041±0.2°、8.238±0.2°、10.260±0.2°、10.578±0.2°、12.142±0.2°、12.941±0.2°、13.601±0.2°、14.922±0.2°、15.980±0.2°、17.417±0.2°、17.681±0.2°、18.321±0.2°、18.801±0.2°、19.241±0.2°、19.721±0.2°、20.420±0.2°、20.658±0.2°、21.218±0.2°、22.541±0.2°、23.379±0.2°、24.478±0.2°、24.898±0.2°、26.499±0.2°、27.420±0.2°、28.239±0.2°、29.461±0.2°、30.040±0.2°、30.839±0.2°、32.119±0.2°、32.318±0.2°、33.419±0.2°、33.741±0.2°、35.561±0.2°、37.720±0.2°,详见附图1。The target compound sample was analyzed by X-ray powder crystal diffraction, and the instrument was analyzed by Rigaku SmartLab diffractometer (unless otherwise specified, the same below). The crystal has characteristic peaks at the following positions, 2θ=3.521±0.2°, 7.041±0.2°, 8.238±0.2°, 10.260±0.2°, 10.578±0.2°, 12.142±0.2°, 12.941±0.2°, 13.601±0.2°, 14.922±0.2°, 15.980±0.2°, 17.417±0.2°, 17.681±0.2°, 18.321±0.2°, 18.801±0.2°, 19.241±0.2°, 19.721±0.2°, 20.420±0.2°, 20.658±0.2°, 21.218±0.2°, 22.541±0.2°, 23.379±0.2°, 24.478±0.2°, 24.898±0.2°, 26.499±0.2°, 27.420±0.2°, 28.239±0.2°, 29.461±0.2°, 30.040±0.2°, 30.839±0.2°, 32.119±0.2°, 32.318±0.2°, 33.419±0.2°, 33.741±0.2°, 35.561±0.2°, 37.720±0.2°, see attached drawing 1 for details.
将本次合成实施例所得样品用3倍重量异丙醚重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of isopropyl ether, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
将本次合成实施例所得样品用3倍重量乙二醇单甲醚重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of ethylene glycol monomethyl ether, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
以上结果说明,所得化合物分别在乙醇、异丙醚、乙二醇单甲醚溶剂中结晶所得结晶体,晶体类型一致,易得且稳定性好。The above results show that the obtained compound is crystallized in ethanol, isopropyl ether, and ethylene glycol monomethyl ether solvents respectively, and the crystals are consistent in type, easy to obtain and good in stability.
合成实施例18Synthetic Example 18
2-氟-3-[(4-氟苯基羰基)(2-甲氧乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-fluoro-3-[(4-fluorophenylcarbonyl)(2-methoxyethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3- Synthetic preparation of heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]benzamide.
250ml的四口玻璃反应瓶中,投入二氯乙烷200g,合成实施例13得到的2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25g(0.071mol),氯化亚砜24g(0.20mol),升温回流反应3-5小时,降温至室温,反应液转移至500ml旋转蒸发器中,减压脱溶至80℃,得到酰氯油状液体,降温至25℃左右,加入新的二氯乙烷150g溶解,转移至反应瓶中,并加入4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-2-(三氟甲基)苯胺原料27.8g(0.08mol),升温回流反应5-10小时。降温至室温,加入氢氧化钠5g,在35-55℃,2小时左右滴入液溴13.5g反应,保温2小时,加入水50ml,分层分去水层,得到溶剂层减压脱溶,得到残余料,加入乙二醇单甲醚120g,升温回流1小时,降温结晶,在0-5℃结晶1小时,过滤干燥得到白色结晶粉末固体44g,为目标化合物,熔点:152.4-153.2℃,HPLC归一含量98%左右,三步总收率83.7%。反应式如下:In a 250ml four-necked glass reaction flask, drop into 200g of dichloroethane, and synthesize 2-fluoro-3-[(2-methoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 25g obtained in Example 13 (0.071mol), 24g (0.20mol) of thionyl chloride, heated and refluxed for 3-5 hours, cooled to room temperature, the reaction solution was transferred to a 500ml rotary evaporator, and desolvated to 80°C under reduced pressure to obtain an acid chloride oily liquid. Cool down to about 25°C, add 150g of new dichloroethane to dissolve, transfer to the reaction bottle, and add 4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2- (Trifluoromethyl) aniline raw material 27.8g (0.08mol), heated and refluxed for 5-10 hours. Cool down to room temperature, add 5g of sodium hydroxide, add 13.5g of liquid bromine dropwise at 35-55°C for about 2 hours to react, keep warm for 2 hours, add 50ml of water, separate the layers to remove the water layer, and obtain the solvent layer. Desolvation under reduced pressure, To obtain the residue, add 120 g of ethylene glycol monomethyl ether, heat up and reflux for 1 hour, cool down to crystallize, crystallize at 0-5°C for 1 hour, filter and dry to obtain 44 g of white crystalline powder solid, which is the target compound, melting point: 152.4-153.2°C, The HPLC normalized content is about 98%, and the three-step total yield is 83.7%. The reaction formula is as follows:
核磁氢谱、质谱数据如下:The H NMR and mass spectrometry data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.56(s,1H,CONH),8.38(s,1H),7.92(s,1H),7.65(dd,J=7.6Hz,and 6.8Hz,1H),7.60-7.49(m,1H),7.42-7.20(m,3H),7.10-7.02(m,2H),4.10-3.70(m,2H),3.68-3.42(m,2H),3.19(s,3H,CH3O)。 1 H-NMR (400MHz, DMSO-d6) δ (ppm): 10.56 (s, 1H, CONH), 8.38 (s, 1H), 7.92 (s, 1H), 7.65 (dd, J = 7.6Hz, and 6.8 Hz,1H),7.60-7.49(m,1H),7.42-7.20(m,3H),7.10-7.02(m,2H),4.10-3.70(m,2H),3.68-3.42(m,2H), 3.19 (s,3H,CH3O).
HRMS(ESI)calcd.for C27H17BrF12N2NaO3[(M+Na)+]:747.0129[(M+Na)+],749.0108[(M+2+Na)+];Found:747.0111[(M+Na)+],749.0094[(M+2+Na)+]。HRMS(ESI)calcd.for C 27 H 17 BrF12N 2 NaO 3 [(M+Na)+]:747.0129[(M+Na)+],749.0108[(M+2+Na)+]; Found:747.0111[ (M+Na)+], 749.0094[(M+2+Na)+].
目标化合物样品经X-射线粉末晶体衍射分析,结晶体在如下位置有特征峰,2θThe target compound sample is analyzed by X-ray powder crystal diffraction, and the crystal has characteristic peaks at the following positions, 2θ
=7.376±0.2°、9.897±0.2°、10.940±0.2°、12.015±0.2°、12.303±0.2°、14.398±0.2°、14.578±0.2°、15.561±0.2°、15.839±0.2°、17.163±0.2°、18.257±0.2°、18.463±0.2°、18.737±0.2°、18.922±0.2°、19.219±0.2°、19.518±0.2°、19.823±0.2°、20.137±0.2°、20.379±0.2°、20.600±0.2°、20.861±0.2°、21.023±0.2°、21.722±0.2°、22.021±0.2°、22.218±0.2°、22.818±0.2°、23.999±0.2°、24.738±0.2°、25.077±0.2°、25.481±0.2°、25.860±0.2°、27.161±0.2°、27.682±0.2°、29.058±0.2°、29.323±0.2°、29.760±0.2°、29.940±0.2°,详见附图2。=7.376±0.2°, 9.897±0.2°, 10.940±0.2°, 12.015±0.2°, 12.303±0.2°, 14.398±0.2°, 14.578±0.2°, 15.561±0.2°, 15.839±0.2°, 17.163±0.2° , 18.257±0.2°, 18.463±0.2°, 18.737±0.2°, 18.922±0.2°, 19.219±0.2°, 19.518±0.2°, 19.823±0.2°, 20.137±0.2°, 20.379±0.2°, 20.600±0.2° , 20.861±0.2°, 21.023±0.2°, 21.722±0.2°, 22.021±0.2°, 22.218±0.2°, 22.818±0.2°, 23.999±0.2°, 24.738±0.2°, 25.077±0.2°, 25.481±0.2° , 25.860±0.2°, 27.161±0.2°, 27.682±0.2°, 29.058±0.2°, 29.323±0.2°, 29.760±0.2°, 29.940±0.2°.
将本次合成实施例所得样品用3倍重量乙醇重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of ethanol, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
将本次合成实施例所得样品用3倍重量异丙醚重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of isopropyl ether, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
以上结果说明,所得化合物分别在乙醇、异丙醚、乙二醇单甲醚溶剂中结晶所得结晶体,晶体类型一致,易得且稳定性好。The above results show that the obtained compound is crystallized in ethanol, isopropyl ether, and ethylene glycol monomethyl ether solvents respectively, and the crystals are consistent in type, easy to obtain and good in stability.
合成实施例19Synthetic Example 19
2-氟-3-[(4-氟苯基羰基)(2-甲氧乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-fluoro-3-[(4-fluorophenylcarbonyl)(2-methoxyethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3- Synthetic preparation of heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]benzamide.
按照合成实施例18的操作,其中2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25g(0.071mol)用合成实施例10所得到的2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25.6g(0.071mol)代替,最后得到白色结晶粉末固体42g,为目标化合物,熔点:152.4-153.2℃,HPLC归一含量98%左右,三步总收率79.9%。样品经核磁、质谱、X-射线粉末晶体衍射分析,结果完全一致。According to the operation of Synthesis Example 18, wherein 25 g (0.071 mol) of 2-fluoro-3-[(2-methoxyethyl) (4-fluorophenylcarbonyl) amino] benzoic acid was obtained from Synthesis Example 10 with 2 -Fluoro-3-[(2-methoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 25.6g (0.071mol) instead, finally obtained 42g of white crystalline powder solid, which was the target compound, melting point: 152.4- 153.2°C, HPLC normalized content about 98%, three-step total yield 79.9%. The samples were analyzed by NMR, mass spectrometry and X-ray powder crystal diffraction, and the results were completely consistent.
合成实施例20Synthetic Example 20
2-氟-3-[(4-氟苯基羰基)(2-乙氧乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-fluoro-3-[(4-fluorophenylcarbonyl)(2-ethoxyethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3- Synthetic preparation of heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]benzamide.
250ml的四口玻璃反应瓶中,投入二氯乙烷200g,合成实施例8得到的2-氟-3-[(2-乙氧乙基)(4-氟苯基羰基)氨基]苯甲酸26g(0.071mol),氯化亚砜24g(0.20mol),升温回流反应3-5小时,降温至室温,反应液转移至500ml旋转蒸发器中,减压脱溶至80℃,得到酰氯油状液体,降温至25℃左右,加入甲苯150g溶解,转移至反应瓶中,并加入4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-2-(三氟甲基)苯胺原料27.8g(0.08mol),升温回流反应5-10小时,减压脱溶得到残余料,加入甲醇120g,降温至室温,加入氢氧化钠5g,在35-55℃,2小时左右滴入液溴13.5g反应,保温2小时,加入水50ml,分层分去水层,得到溶剂层减压脱溶,得到残余料,加入异丙醚120g,升温回流1小时,降温结晶,在0-5℃结晶1小时,过滤干燥得到白色结晶粉末固体44.5g,为目标化合物,熔点:168.2-169.2℃,HPLC归一含量98%左右,三步总收率83.1%。反应式如下:In the four-necked glass reaction bottle of 250ml, drop into dichloroethane 200g, the 2-fluoro-3-[(2-ethoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 26g that synthesis embodiment 8 obtains (0.071mol), 24g (0.20mol) of thionyl chloride, heated and refluxed for 3-5 hours, cooled to room temperature, the reaction solution was transferred to a 500ml rotary evaporator, and desolvated to 80°C under reduced pressure to obtain an acid chloride oily liquid. Cool down to about 25°C, add 150g of toluene to dissolve, transfer to the reaction flask, and add 4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-(trifluoromethyl ) 27.8g (0.08mol) of aniline raw material, heated and refluxed for 5-10 hours, desolvated under reduced pressure to obtain the residue, added 120g of methanol, cooled to room temperature, added 5g of sodium hydroxide, and dripped in about 2 hours at 35-55°C Put 13.5g of bromine into the liquid to react, keep warm for 2 hours, add 50ml of water, separate and separate the water layer, obtain the solvent layer and precipitate under reduced pressure to obtain the residual material, add 120g of isopropyl ether, heat up and reflux for 1 hour, cool down and crystallize, at 0 Crystallize at -5°C for 1 hour, filter and dry to obtain 44.5 g of white crystalline powder solid, which is the target compound, melting point: 168.2-169.2°C, HPLC normalized content of about 98%, and the total yield of three steps is 83.1%. The reaction formula is as follows:
核磁氢谱、质谱数据如下:The H NMR and mass spectrometry data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.52(s,1H,CONH),8.38(s,1H),7.92(s,1H),7.67(dd,J=7.6Hz,and 6.8Hz,1H),7.60-7.50(m,1H),7.48-7.20(m,3H),7.18-6.95(m,2H),4.20-3.72(m,2H),3.68-3.45(m,2H),3.42-3.32(m,2H),1.01(t,J=6.8Hz,3H,CH3)。 1 H-NMR (400MHz, DMSO-d6) δ (ppm): 10.52 (s, 1H, CONH), 8.38 (s, 1H), 7.92 (s, 1H), 7.67 (dd, J = 7.6Hz, and 6.8 Hz,1H),7.60-7.50(m,1H),7.48-7.20(m,3H),7.18-6.95(m,2H),4.20-3.72(m,2H),3.68-3.45(m,2H), 3.42-3.32 (m, 2H), 1.01 (t, J = 6.8Hz, 3H, CH3).
HRMS(ESI)calcd.For C28H19BrF12N2NaO3[(M+Na)+]:761.0285[(M+Na)+],763.0265[(M+2+Na)+];Found:761.0263[(M+Na)+],763.0248[(M+2+Na)+]。HRMS(ESI) calcd. For C 28 H 19 BrF 12 N 2 NaO 3 [(M+Na) + ]: 761.0285[(M+Na) + ], 763.0265[(M+2+Na) + ]; Found: 761.0263[(M+Na) + ], 763.0248[(M+2+Na) + ].
目标化合物样品经X-射线粉末晶体衍射分析,结晶体在如下位置有特征峰,2θThe target compound sample is analyzed by X-ray powder crystal diffraction, and the crystal has characteristic peaks at the following positions, 2θ
=7.318±0.2°、9.697±0.2°、10.940±0.2°、11.981±0.2°、12.136±0.2°、14.142±0.2°、14.461±0.2°、15.240±0.2°、15.561±0.2°、16.304±0.2°、17.161±0.2°、17.979±0.2°、18.562±0.2°、19.138±0.2°、19.698±0.2°、20.039±0.2°、20.220±0.2°、20.442±0.2°、20.784±0.2°、20.998±0.2°、21.819±0.2°、22.039±0.2°、22.401±0.2°、23.400±0.2°、23.882±0.2°、24.383±0.2°、24.579±0.2°、25.001±0.2°、25.160±0.2°、25.459±0.2°、26.780±0.2°、26.920±0.2°、27.199±0.2°、27.378±0.2°、28.742±0.2°、29.319±0.2°、29.998±0.2°、31.339±0.2°、31.939±0.2°、32.140±0.2°、32.522±0.2°、33.479±0.2°、36.400±0.2°、43.039±0.2°,详见附图3。=7.318±0.2°, 9.697±0.2°, 10.940±0.2°, 11.981±0.2°, 12.136±0.2°, 14.142±0.2°, 14.461±0.2°, 15.240±0.2°, 15.561±0.2°, 16.304±0.2° , 17.161±0.2°, 17.979±0.2°, 18.562±0.2°, 19.138±0.2°, 19.698±0.2°, 20.039±0.2°, 20.220±0.2°, 20.442±0.2°, 20.784±0.2°, 20.998±0.2° , 21.819±0.2°, 22.039±0.2°, 22.401±0.2°, 23.400±0.2°, 23.882±0.2°, 24.383±0.2°, 24.579±0.2°, 25.001±0.2°, 25.160±0.2°, 25.459±0.2° , 26.780±0.2°, 26.920±0.2°, 27.199±0.2°, 27.378±0.2°, 28.742±0.2°, 29.319±0.2°, 29.998±0.2°, 31.339±0.2°, 31.939±0.2°, 32.140±0.2° , 32.522±0.2°, 33.479±0.2°, 36.400±0.2°, 43.039±0.2°, see attached drawing 3 for details.
将本次合成实施例所得样品用3倍重量乙醇重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of ethanol, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
将本次合成实施例所得样品用3倍重量乙二醇单甲醚重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of ethylene glycol monomethyl ether, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
将本次合成实施例所得样品用3倍重量乙二醇二甲醚重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The sample obtained in this synthesis example was recrystallized with 3 times the weight of ethylene glycol dimethyl ether, and the finally obtained sample was analyzed by X-ray powder crystal diffraction, and the crystal characteristic peaks were completely consistent with the above.
说明,化合物分别在乙醇、异丙醚、乙二醇单甲醚、乙二醇二甲醚溶剂中结晶所得结晶体,晶体类型一致,易得且稳定性好。It shows that the crystals obtained by crystallizing the compound in ethanol, isopropyl ether, ethylene glycol monomethyl ether, and ethylene glycol dimethyl ether solvents respectively have the same crystal type, are easy to obtain and have good stability.
将本次合成实施例所得样品分别用3倍重量的甲醇、异丙醇、四氢呋喃、乙二醇单乙醚、乙二醇二乙醚、甲基叔丁基醚重结晶,最后得到的样品,经X-射线粉末晶体衍射分析,结晶体特征峰和上面完全一致。The samples obtained in this synthesis example were recrystallized with 3 times the weight of methanol, isopropanol, tetrahydrofuran, ethylene glycol monoethyl ether, ethylene glycol diethyl ether, and methyl tert-butyl ether, and the finally obtained samples were subjected to X - X-ray powder crystal diffraction analysis, the crystal characteristic peaks are exactly the same as above.
说明,化合物分别在甲醇、乙醇、异丙醇、四氢呋喃、异丙醚、乙二醇单甲醚、乙二醇单乙醚、乙二醇二甲醚、乙二醇二乙醚、甲基叔丁基醚等溶剂中结晶所得结晶体,晶体类型一致,易得且稳定性好。Note that the compounds are respectively in methanol, ethanol, isopropanol, tetrahydrofuran, isopropyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, methyl tert-butyl The crystals obtained by crystallization in solvents such as ether have consistent crystal types, are easy to obtain and have good stability.
合成实施例21Synthetic Example 21
2-氟-3-[(苯基羰基)(甲基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-Fluoro-3-[(phenylcarbonyl)(methyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)- Synthetic preparation of 6-(trifluoromethyl)phenyl]benzamide.
按照合成实施例18的操作,其中原料2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25g(0.071mol)用合成实施例11所得2-氟-3-[(甲基)(苯基羰基)氨基]苯甲酸20.4g(0.071mol)代替。其他操作相同,最后得到白色结晶粉末固体40.1g,为目标化合物,熔点:155.1-156.4℃,HPLC归一含量98%左右,三步总收率83.4%。反应式如下:According to the operation of Synthesis Example 18, 25 g (0.071 mol) of the raw material 2-fluoro-3-[(2-methoxyethyl) (4-fluorophenylcarbonyl) amino]benzoic acid was obtained from Synthesis Example 11 with 2- Fluoro-3-[(methyl)(phenylcarbonyl)amino]benzoic acid was replaced by 20.4 g (0.071 mol). Other operations were the same, and finally 40.1 g of white crystalline powder solid was obtained, which was the target compound, melting point: 155.1-156.4°C, HPLC normalized content about 98%, and the total yield of three steps was 83.4%. The reaction formula is as follows:
核磁氢谱、质谱数据如下:The H NMR and mass spectrometry data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.65(s,1H,CONH),8.39(s,1H),7.93(s,1H),7.61-7.51(m,2H),7.45-7.15(m,6H),3.32(s,3H)。 1 H-NMR (400MHz, DMSO-d6) δ (ppm): 10.65 (s, 1H, CONH), 8.39 (s, 1H), 7.93 (s, 1H), 7.61-7.51 (m, 2H), 7.45- 7.15 (m, 6H), 3.32 (s, 3H).
HRMS(ESI)calcd.for C25H14BrF11N2NaO2[(M+Na)+]:684.9961[(M+Na)+],686.9940[(M+2+Na)+];Found:684.9956[(M+Na)+],686.9940[(M+2+Na)+]。HRMS(ESI)calcd.for C 25 H 14 BrF 11 N 2 NaO 2 [(M+Na)+]:684.9961[(M+Na)+],686.9940[(M+2+Na)+]; Found: 684.9956[(M+Na)+], 686.9940[(M+2+Na)+].
合成实施例22Synthetic Example 22
2-氟-3-[(苯基羰基)(乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-Fluoro-3-[(phenylcarbonyl)(ethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)- Synthetic preparation of 6-(trifluoromethyl)phenyl]benzamide.
按照合成实施例18的操作,其中原料2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25g(0.071mol)用合成实施例12所得2-氟-3-[(乙基)(苯基羰基)氨基]苯甲酸21.4g(0.071mol)代替。其他操作相同,最后得到白色结晶粉末固体40g,为目标化合物,熔点:166.1-167.8℃,HPLC归一含量98%左右,三步总收率81.5%。反应式如下:According to the operation of Synthesis Example 18, 25 g (0.071 mol) of raw material 2-fluoro-3-[(2-methoxyethyl) (4-fluorophenylcarbonyl) amino]benzoic acid was obtained from Synthesis Example 12 with 2- Fluoro-3-[(ethyl)(phenylcarbonyl)amino]benzoic acid 21.4 g (0.071 mol) was substituted. Other operations were the same, and finally 40 g of white crystalline powder solid was obtained, which was the target compound, melting point: 166.1-167.8° C., HPLC normalized content of about 98%, and the total yield of three steps was 81.5%. The reaction formula is as follows:
合成实施例23Synthetic Example 23
2-氟-3-[(4-氟苯基羰基)(环丙基甲基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-Fluoro-3-[(4-fluorophenylcarbonyl)(cyclopropylmethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropane Synthetic preparation of -2-yl)-6-(trifluoromethyl)phenyl]benzamide.
按照合成实施例18的操作,其中原料2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25g(0.071mol)用合成实施例14所得2-氟-3-[(环丙基甲基)(4-氟苯基羰基)氨基]苯甲酸23.4g(0.071mol)代替。其他操作相同,最后得到白色结晶粉末固体43g,为目标化合物,熔点:152.5-153.3℃,HPLC归一含量98%左右,三步总收率82.3%。反应式如下:According to the operation of Synthesis Example 18, 25 g (0.071 mol) of raw material 2-fluoro-3-[(2-methoxyethyl) (4-fluorophenylcarbonyl) amino] benzoic acid was obtained from Synthesis Example 14 with 2- Fluoro-3-[(cyclopropylmethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 23.4 g (0.071 mol) was substituted. Other operations were the same, and finally 43 g of white crystalline powder solid was obtained, which was the target compound, melting point: 152.5-153.3° C., HPLC normalized content of about 98%, and the total yield of three steps was 82.3%. The reaction formula is as follows:
合成实施例24Synthetic Example 24
2-氟-3-[(4-氰基苯基羰基)(2-乙氧乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺的合成制备。2-fluoro-3-[(4-cyanophenylcarbonyl)(2-ethoxyethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3 Synthetic preparation of -heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]benzamide.
按照参考合成准备实施例5操作,其中苯甲酸25g(0.20mol)用对氰基苯甲酸29.5g(0.20mol)代替,其他操作相同,合成得到2-氟-3-[(4-氰基苯基羰基)氨基]苯甲酸甲酯,并取27.2g(0.086mol)代替合成实施例13中原料2-氟-3-[(4-氟苯基羰基)氨基]苯甲酸甲酯物料26.7g(0.086mol),同时用1-溴-2-乙氧基乙烷16.8g(0.11mol)代替合成实施例13中原料1-溴-2-甲氧基乙烷15.8g(0.11mol),其他操作相同,合成得到的2-氟-3-[(2-乙氧乙基)(4-氰基苯基羰基)氨基]苯甲酸,并取26.6g(0.071mol)代替合成实施例18中原料2-氟-3-[(2-甲氧乙基)(4-氟苯基羰基)氨基]苯甲酸25g(0.071mol),其他操作相同,最后得到米白色结晶粉末固体43.4g,为目标化合物,熔点:150.1-152.2℃,HPLC归一含量98%左右,后三步总收率80.3%。反应式如下:According to the reference synthesis preparation example 5, 25 g (0.20 mol) of benzoic acid is replaced by 29.5 g (0.20 mol) of p-cyanobenzoic acid, and the other operations are the same, and 2-fluoro-3-[(4-cyanobenzene is synthesized. Base carbonyl) amino] methyl benzoate, and get 27.2g (0.086mol) to replace raw material 2-fluoro-3-[(4-fluorophenylcarbonyl) amino] methyl benzoate material 26.7g in synthesis embodiment 13 ( 0.086mol), while using 1-bromo-2-ethoxyethane 16.8g (0.11mol) to replace raw material 1-bromo-2-methoxyethane 15.8g (0.11mol) in Synthesis Example 13, other operations Same, synthesize the obtained 2-fluoro-3-[(2-ethoxyethyl)(4-cyanophenylcarbonyl)amino]benzoic acid, and take 26.6g (0.071mol) to replace raw material 2 in Synthesis Example 18 -Fluoro-3-[(2-methoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 25g (0.071mol), other operations are the same, and finally 43.4g of off-white crystalline powder solid is obtained, which is the target compound, Melting point: 150.1-152.2°C, HPLC normalized content is about 98%, and the total yield of the last three steps is 80.3%. The reaction formula is as follows:
核磁氢谱、质谱数据如下:The H NMR and mass spectrometry data are as follows:
1H-NMR(400MHz,DMSO-d6)δ(ppm):10.48(s,1H,CONH),8.39(s,1H),7.92(s,1H),7.72-7.65(m,3H),7.58-7.50(m,1H),7.48-7.35(m,2H),7.32(dd,J=7.2Hz,and 7.2Hz,1H),4.15-3.85(m,2H),3.70-3.50(m,2H),3.44-3.32(m,2H),1.00(t,J=6.0Hz,3H,CH3)。1H-NMR(400MHz,DMSO-d6)δ(ppm):10.48(s,1H,CONH),8.39(s,1H),7.92(s,1H),7.72-7.65(m,3H),7.58-7.50 (m,1H),7.48-7.35(m,2H),7.32(dd,J=7.2Hz,and 7.2Hz,1H),4.15-3.85(m,2H),3.70-3.50(m,2H),3.44 -3.32 (m, 2H), 1.00 (t, J=6.0Hz, 3H, CH3).
HRMS(ESI)calcd.for C29H19BrF11N3NaO3[(M+Na)+]:768.0332[(M+Na)+],770.0311[(M+2+Na)+];Found:768.0310[(M+Na)+],770.0293[(M+2+Na)+]。HRMS(ESI)calcd.for C 29 H 19 BrF 11 N 3 NaO 3 [(M+Na)+]:768.0332[(M+Na)+],770.0311[(M+2+Na)+]; Found: 768.0310 [(M+Na)+], 770.0293 [(M+2+Na)+].
合成实施例25Synthetic Example 25
按照合成实施例13的操作,其中1-溴-2-甲氧基乙烷15.8g(0.11mol)用1-溴-2-正丙氧基乙烷18.7g(0.11mol)代替,其他投料及操作相同,得到的中间体2-氟-3-[(2-正丙氧乙基)(4-氟苯基羰基)氨基]苯甲酸收率及含量结果相似。目标化合物合成按照合成实施例20相似的操作,其中原料2-氟-3-[(2-乙氧乙基)(4-氟苯基羰基)氨基]苯甲酸26g(0.071mol)用上面得到的2-氟-3-[(2-正丙氧乙基)(4-氟苯基羰基)氨基]苯甲酸27g(0.071mol)代替,其他操作相似,最后得到目标化合物:2-氟-3-[(4-氟苯基羰基)(2-正丙氧乙基)氨基]-N-[2-溴-4-(1,1,1,2,3,3,3-七氟丙烷-2-基)-6-(三氟甲基)苯基]苯甲酰胺,熔点:156.5-156.8,收率及含量结果相似。According to the operation of Synthesis Example 13, 15.8g (0.11mol) of 1-bromo-2-methoxyethane was replaced by 18.7g (0.11mol) of 1-bromo-2-n-propoxyethane, and other materials and The operation is the same, and the yield and content of the intermediate 2-fluoro-3-[(2-n-propoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid obtained are similar. The target compound was synthesized according to the similar operation of Synthesis Example 20, wherein the raw material 2-fluoro-3-[(2-ethoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 26g (0.071mol) was obtained from above 2-fluoro-3-[(2-propoxyethyl)(4-fluorophenylcarbonyl)amino]benzoic acid 27g (0.071mol) instead, other operations were similar, and finally the target compound was obtained: 2-fluoro-3- [(4-fluorophenylcarbonyl)(2-n-propoxyethyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl )-6-(trifluoromethyl)phenyl]benzamide, melting point: 156.5-156.8, yield and content are similar.
本发明的其他通式(Ⅰ)或(Ⅱ)化合物可以参考上述实施例方法合成。Other compounds of general formula (I) or (II) of the present invention can be synthesized with reference to the methods in the above examples.
生物活性测试实施例Example of biological activity test
用本发明获得的部分通式(Ⅱ)化合物对多种害虫进行了试验。A variety of pests have been tested with some compounds of the general formula (II) obtained in the present invention.
化合物配制:用天平(0.001g)称取一定质量的原药,用DMF配制成1%母液,然后用含0.1%吐温-80的蒸馏水稀释成试验浓度备用;如果是制剂的,按照制剂活性成分含量,用天平(0.001g)称取一定质量的制剂样品,用蒸馏水稀释成试验浓度备用。Compound preparation: take a certain quality of the original drug with a balance (0.001g), prepare a 1% mother solution with DMF, then dilute it with distilled water containing 0.1% Tween-80 to a test concentration for later use; For component content, take a certain quality preparation sample with a balance (0.001g), and dilute it with distilled water to a test concentration for later use.
表1:部分通式(Ⅱ)化合物Table 1: Some compounds of general formula (II)
测试实施例1部分通式(Ⅱ)化合物对小菜蛾室内生物活性测定Test embodiment 1 part general formula (II) compound is to diamondback moth indoor biological activity assay
小菜蛾(Plutella xylostella)敏感种群及抗氯虫酰胺种群,室内以萝卜苗饲养;The sensitive population of diamondback moth (Plutella xylostella) and the population resistant to chlorantraniliprole were reared with radish seedlings indoors;
试验方法:小菜蛾活性测定:采用浸渍法,取适量萝卜叶浸药30s后,置于垫有滤纸的塑料培养皿中自然阴干,每皿接2龄小菜蛾10头,置于22℃、光照(16/8h)观察室内。2天后观察,以毛笔轻触虫体,无反应视为死虫,重复3次,另设不加药剂的空白对照。Test method: Determination of Plutella xylostella activity: Using the dipping method, take an appropriate amount of radish leaves and soak them in the drug for 30 seconds, and then place them in a plastic petri dish lined with filter paper to dry naturally in the shade. Take 10 2-year-old Plutella xylostella in each dish, and place them at 22°C under light. (16/8h) Observation room. Observe after 2 days, lightly touch the worm body with a brush, if there is no response, it is regarded as a dead worm, repeat 3 times, and set up a blank control without adding medicine.
试验结果:部分通式(Ⅱ)化合物SYN101等对小菜蛾的活性测定结果如表二所示:Result of the test: some general formula (II) compound SYN101 etc. are shown in table two to the active assay result of diamondback moth:
结果表明:在所试验浓度0.2mg/L,0.1mg/L,0.05mg/L时,化合物SYN101、SYN102、SYN103、SYN104、SYN105、SYN106、SYN107对小菜蛾敏感种群的活性及小菜蛾抗氯虫酰胺种群活性均表现出优异的杀虫活性,均大于80%,在低浓度0.05mg/L时,SYN104、SYN105、SYN106、SYN107对小菜蛾敏感种群的活性及小菜蛾抗氯虫酰胺种群活性仍表现出优异的杀虫活性,均达100%。The results show that: at the test concentration of 0.2mg/L, 0.1mg/L, and 0.05mg/L, the activity of compounds SYN101, SYN102, SYN103, SYN104, SYN105, SYN106, and SYN107 on the sensitive populations of Plutella xylostella and the resistance of Plutella xylostella The amide population activity all showed excellent insecticidal activity, all greater than 80%. At a low concentration of 0.05mg/L, the activity of SYN104, SYN105, SYN106, and SYN107 on the sensitive population of Plutella xylostella and the activity of Plutella xylostella resistant to chlorantraniliprole remained the same. Exhibit excellent insecticidal activity, all up to 100%.
表2:部分通式(Ⅱ)化合物对小菜蛾的活性测定结果Table 2: The activity measurement result of some general formula (Ⅱ) compounds to Plutella xylostella
测试实施例2部分通式(Ⅱ)化合物对草地贪夜蛾的室内生物活性测定Test embodiment 2 part general formula (II) compound is to the indoor biological activity determination of Spodoptera frugiperda
草地贪夜蛾活性测定:采用浸渍法,取适量玉米叶浸药30s后,置于垫有滤纸的塑料培养皿中自然阴干,每皿接2龄草地贪夜蛾10头,置于26℃、光照(16/8h)观察室内。2天后观察,以毛笔轻触虫体,无反应视为死虫,重复3次,另设不加药剂的空白对照。Determination of the activity of Spodoptera frugiperda: Using the dipping method, take an appropriate amount of corn leaves to soak the drug for 30 seconds, put it in a plastic petri dish lined with filter paper and dry it naturally in the shade, pick up 10 2-year-old Spodoptera frugiperda in each dish, and place it at 26°C. Light (16/8h) observation room. Observe after 2 days, lightly touch the worm body with a brush, if there is no response, it is regarded as a dead worm, repeat 3 times, and set up a blank control without adding medicine.
试验结果:部分通式(Ⅱ)化合物SYN101等对草地贪夜蛾的室内生物活性测定试验结果见表3所示:Test results: some general formula (II) compounds SYN101 etc. are shown in Table 3 to the indoor biological activity assay test results of Spodoptera frugiperda:
结果表明:化合物SYN101、SYN102、SYN103在供试浓度0.2mg/L时均有较好的活性,达100%,在供试浓度0.1mg/L时,活性稍差,但均大于80%,在供试浓度0.05mg/L时,活性较差。在供试浓度0.2mg/L时,0.1mg/L,0.05mg/L时,化合物SYN104、SYN105、SYN106、SYN107,均表现出优异的杀虫活性,均达100%。The result shows: compound SYN101, SYN102, SYN103 all have good activity when test concentration 0.2mg/L, reach 100%, when test concentration 0.1mg/L, activity is slightly poor, but all greater than 80%, in When the test concentration is 0.05mg/L, the activity is poor. When the test concentration was 0.2mg/L, 0.1mg/L, and 0.05mg/L, the compounds SYN104, SYN105, SYN106, and SYN107 all showed excellent insecticidal activity, reaching 100%.
表3:部分通式(Ⅱ)化合物对草地贪夜蛾的活性测定结果Table 3: The results of the activity assay of some general formula (II) compounds on Spodoptera frugiperda
本申请人声明,本发明通过上述代表性的实施例来说明一种含七氟异丙基的双酰胺类化合物及其中间体的制备方法,但本发明并不局限于上述实施例,也不意味着本发明必须依赖上述实施例才能实现。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant declares that the present invention illustrates a preparation method of a heptafluoroisopropyl-containing bisamide compound and its intermediate through the above representative examples, but the present invention is not limited to the above examples, nor It means that the present invention can only be realized by relying on the above-mentioned embodiments. Those skilled in the art should understand that any improvement of the present invention, the equivalent replacement of each raw material of the product of the present invention, the addition of auxiliary components, the selection of specific methods, etc., all fall within the scope of protection and disclosure of the present invention.
Claims (13)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111583506 | 2021-12-22 | ||
CN2021115835066 | 2021-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115974717A true CN115974717A (en) | 2023-04-18 |
CN115974717B CN115974717B (en) | 2025-03-14 |
Family
ID=85961529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211560250.1A Active CN115974717B (en) | 2021-12-22 | 2022-12-07 | Bisamide compound containing sevoflurane isopropyl and intermediate compound thereof, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115974717B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116987044A (en) * | 2023-09-28 | 2023-11-03 | 山东亿嘉农化有限公司 | Synthesis process of 4- (p-chlorophenyl) -2-trifluoromethyl-3-oxazol-5-one |
WO2024087613A1 (en) * | 2022-10-24 | 2024-05-02 | 浙江宇龙药业有限公司 | Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation methods therefor and use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102119144A (en) * | 2008-08-13 | 2011-07-06 | 三井化学Agro株式会社 | Method for producing amide derivative |
CN104245665A (en) * | 2012-04-03 | 2014-12-24 | 三井化学Agro株式会社 | Method for producing alkylated aromatic amide derivative |
CN108586279A (en) * | 2018-06-26 | 2018-09-28 | 上海泰禾国际贸易有限公司 | One inter-species diamide compound and its preparation method and application |
-
2022
- 2022-12-07 CN CN202211560250.1A patent/CN115974717B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102119144A (en) * | 2008-08-13 | 2011-07-06 | 三井化学Agro株式会社 | Method for producing amide derivative |
CN104245665A (en) * | 2012-04-03 | 2014-12-24 | 三井化学Agro株式会社 | Method for producing alkylated aromatic amide derivative |
CN108586279A (en) * | 2018-06-26 | 2018-09-28 | 上海泰禾国际贸易有限公司 | One inter-species diamide compound and its preparation method and application |
Non-Patent Citations (1)
Title |
---|
吴俊威: "取代型N-烷基化反应专利技术综述", 《精细化工中间体》, vol. 45, no. 2, 28 April 2015 (2015-04-28), pages 1 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024087613A1 (en) * | 2022-10-24 | 2024-05-02 | 浙江宇龙药业有限公司 | Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation methods therefor and use thereof |
CN116987044A (en) * | 2023-09-28 | 2023-11-03 | 山东亿嘉农化有限公司 | Synthesis process of 4- (p-chlorophenyl) -2-trifluoromethyl-3-oxazol-5-one |
CN116987044B (en) * | 2023-09-28 | 2024-01-26 | 山东亿嘉农化有限公司 | Synthesis process of 4- (p-chlorophenyl) -2-trifluoromethyl-3-oxazol-5-one |
Also Published As
Publication number | Publication date |
---|---|
CN115974717B (en) | 2025-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103387541B (en) | A kind of preparation method of substituted pyrazolecarboxylic ether compound | |
CN115974717A (en) | Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation method and application thereof | |
CN110317177B (en) | Preparation method of pyrimidine salicylate oxime ester compound and application as herbicide | |
JP2021066723A (en) | Preparation method for m-diamide compounds | |
CN102503876A (en) | Bisamide derivative, preparation method for same and application thereof | |
CN116947679B (en) | Bisamide compound containing sevoflurane isopropyl, and preparation method and application thereof | |
CN105693603B (en) | The maleic acid datro preparation process of improvement | |
CN115260175A (en) | 5- (pyrazole-5-yl) -1,2,4-oxadiazole substituted benzamide compound and preparation method and application thereof | |
CA2558051A1 (en) | Palladium catalyzed indolization of 2-bromo or chloroanilines | |
TWI316939B (en) | Process for the preparation of organic compounds | |
CN106831683A (en) | A kind of cumarin aryloxy acetic acids ester type compound and its application on agricultural chemicals | |
CN109265381B (en) | Cyano-containing phthalic diamide derivative and preparation and application thereof | |
WO2024087613A1 (en) | Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation methods therefor and use thereof | |
CN114478425B (en) | Synthetic method of aryloxy phenoxy propionate herbicide | |
CN110256359A (en) | 2- aminobenzimidazole derivative and its synthesis and application | |
WO2024152641A1 (en) | Preparation method for 3-chlorobicyclo[3.2.1]-3-octen-2-ol | |
EP0493606A1 (en) | Heterocycle-substituted benzene derivative, production thereof, and herbicide containing the same as active ingredient | |
TW201908296A (en) | Method for preparing pyrimidinone compound | |
CA1292739C (en) | Heteroaromatic acetylenes useful as antihypertensive agents | |
CN114920734A (en) | 5- (pyrazole-5-yl) -1,2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof | |
CN108484614A (en) | Pyrazolo[3,4-d]pyrimidin-4(5H)-one derivative and its preparation method and application | |
CN110272361B (en) | Phthalic diamide compound containing alkoxy hexafluoroisopropyl and application thereof | |
CN100503563C (en) | Arylpyrrole N-oxalate derivatives and their preparation and application as insecticides | |
CN111072638A (en) | Method for preparing AZD4547, intermediate and preparation method of intermediate | |
CN115557855B (en) | Polysubstituted 2-hydroxybenzophenone compounds and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |